Chemopreventive and Antioxidant Activity of Cichorium Intybus Leaves against Ndea Induced Hepatocarcinogenesis in Wistar Rats by Krishnaveni, E
 
CHEMOPREVENTIVE AND ANTIOXIDANT ACTIVITY 
OF CICHORIUM INTYBUS LEAVES AGAINST NDEA 
INDUCED HEPATOCARCINOGENESIS  
IN WISTAR RATS 
Dissertation submitted to 
THE TAMIL NADU DR. M.G.R. MEDICAL UNIVERSITY 
Chennai-32 
In partial fulfillment of the award of the degree of 
MASTER OF PHARMACY IN 
PHARMACOLOGY 
 
Submitted By 
Reg.No.26113092 
Under The Guidance Of 
Mr. V. Rajesh, M.Pharm., Ph.D., 
 
DEPARTMENT OF PHARMACOLOGY 
J.K.K. NATTRAJA COLLEGE OF PHARMACY 
KOMARAPALAYAM – 638 183 
TAMILNADU. 
OCTOBER – 2013 
 EVALUATION CERTIFICATE 
 
 
This is to certify that the dissertation work entitled “Chemopreventive and 
antioxidant activity of Cichorium Intybus Leaves against NDEA Induced 
Hepatocarcinogenesis in Wistar rats” submitted by the student bearing [Reg. No: 
26113092] to “The Tamil Nadu Dr. M.G.R. Medical University”, Chennai, in 
partial fulfillment for the award of Degree of Master of Pharmacy in 
Pharmacology was evaluated by us during the examination held 
on……………..…..……. 
 
 
 
 
 
 
 
Internal Examiner                                                      External Examiner 
 CERTIFICATE 
 
 
This is to certify that the work embodied in this dissertation entitled 
“Chemopreventive and antioxidant activity of Cichorium Intybus Leaves 
against NDEA Induced Hepatocarcinogenesis in Wistar rats” submitted to “The 
Tamil Nadu Dr. M.G.R. Medical University”, Chennai, in partial fulfillment to 
the requirement for the award of Degree of Master of Pharmacy in 
Pharmacology, is a bonafide work carried out by Miss. E. Krishnaveni, 
[Reg.No.26113092]  during  the  academic  year  2012-2013, under   the guidance 
and supervision of Mr.V.Rajesh, M.Pharm., Ph.D., Assistant professor and Head, 
Department of Pharmacology, J.K.K. Nattraja College of Pharmacy, 
Komarapalayam. 
 
 
 
 
 
 
 
 
 
 
 
 
Place: Komarapalayam Dr.R.SambathKumar, M.Pharm., Ph.D., 
Date:                                                  Professor & Principal, 
                                                         J.K.K. Nattraja College of Pharmacy.  
                                                           Komarapalayam-638 183. 
 CERTIFICATE 
 
 
 
 
          This is to certify that the work embodied in this dissertation entitled 
“Chemopreventive and antioxidant activity of Cichorium Intybus Leaves 
against NDEA Induced Hepatocarcinogenesis in Wistar rats” submitted to “The 
Tamil Nadu Dr. M.G.R. Medical University”, Chennai, in partial fulfillment to 
the requirement for the award of Degree of Master of Pharmacy in 
Pharmacology, is a bonafide work carried out by Miss. E. Krishnaveni, 
[Reg.No.26113092]  during  the  academic  year  2012-2013, under my guidance 
and direct supervision in the Department of Pharmacology, J.K.K. Nattraja College 
of Pharmacy, Komarapalayam. 
 
 
 
 
 
 
 
 
 
 
 
 
Mr. V. Rajesh, M.pharm, Ph.D., 
Assistant Professor & Head, 
Department of Pharmacology, 
J.K.K. Nattraja College of Pharmacy, 
Komarapalayam-638183, 
 
 
 
 
 
  
 
DECLARATION 
 
 
 
 
 
 
I do here by declared that the dissertation entitled “Chemopreventive and 
antioxidant activity of Cichorium Intybus Leaves against NDEA Induced 
Hepatocarcinogenesis in Wistar rats” submitted to “The Tamil Nadu Dr. M.G.R 
Medical University”, Chennai, for the partial fulfillment of the degree of Master of 
Pharmacy in Pharmacology, is a bonafide research work has been carried out by 
me during the academic year 2012-2013, under the guidance and supervision of  
Mr. V. Rajesh, M.Pharm., Ph.D., Assistant professor & Head, Department of 
Pharmacology, J.K.K. Nattraja College of Pharmacy , Komarapalayam . 
 
I further declare that, this work is original and this dissertation has not been 
submitted previously for the award of any other degree, diploma, associate ship and 
fellowship or any other similar title. The information furnished in this dissertation 
is genuine to the best of my knowledge. 
 
 
 
 
 
 
 
 
 
Place : Komarapalayam     E. Krishnaveni, 
Date:          Reg. No.26113092. 
 
  
ACKNOWLEDGEMENT 
 At the outset, I am thankful to JESUS and my parents for blessing me with 
great strength and courage to complete my dissertation. Behind every success there 
are lots of efforts, but efforts are fruitful due to helping hands making the passage 
smoother. So, I am thankful to all those hands and people who made my work grand 
success. 
 I am proud to dedicate my deep sense of gratitude to the founder, (Late) 
Thiru J.K.K. Nattaraja Chettiar, providing us the historical institution to study. 
 My  sincere  thanks  and  respectful  regards  to  our  reverent  Chairperson 
Smt. N. Sendamaraai, B.Com., Managing Director Mr. S. Omm Sharravana, 
B.Com., LLB., and Executive Director Mr. S. Omm Singarravel, B.E., M.S., 
J.K.K. Nattraja Educational Institutions, Komarapalayam for their blessings, 
encouragement and support at all times. 
 It is most pleasant duty to thank our beloved Principal                         
Dr.  R.SambathKumar, M.Pharm., Ph.D., J.K.K.Nattraja College of Pharmacy, 
Komarapalayam for ensuring all the facilities were made available to me for the 
smooth running of this project. 
 I express whole my sincere thanks to my guide Mr. V. Rajesh, M.Pharm., 
Ph.D., Assistant professor and head of Department of Pharmacology, for suggesting 
solution to problems faced by me and providing indispensable guidance, 
tremendous encouragement at each and every step of this dissertation work. Without 
his critical advice and deep-rooted knowledge, this work would not have been a 
reality. 
  
            My sincere thanks to Dr. R. Shanmugasundaram, M.Pharm., Ph.D., 
Professor & Vice Principal, Department of Pharmacology, Mr. C. Sridharan, 
M.Pharm., Lecturer, Department of Pharmacology, Mr. S. Venkatesh, M.Pharm., 
Lecturer, Department of Pharmacology for their valuable suggestions during my 
project work.   
           My sincere thanks to N. Venkateswaramurthy, M.Pharm., Assistant 
Professor and  Head, Department of Pharmacy Practice. Mrs. K. Krishna Veni, 
M.Pharm., Lecturer, Department of Pharmacy Practice, Mrs. Christy John, 
M.Pharm., Lecturer, Department of Pharmacy Practice and Dr. K. Sattanathan, 
M.Pharm., Ph.D., Lecturer Department of pharmacy practice, for their help during 
my project. 
 My sincere thanks to Mrs. S. Bhama, M.Pharm., Assistant Professor,                 
Dr. S.K. Senthilkumar, M.Pharm., Ph.D., Assistant Professor, Mr. R. 
Kanagasabai, B. Pharm. M.Tech., Assistant Professor, Mr. K. Jaganathan, 
M.Pharm., Lecturer, Department of Pharmaceutics, Mr. C. Kannan M.Pharm., 
Lecturer, Department of Pharmaceutics and Mr. Kamalakannan M.Pharm., 
Lecturer, Department of pharmaceutics for their valuable help during my project. 
 It is my privilege to express deepest sense of gratitude toward  Dr. M. 
Vijayabaskaran, M.Pharm., Ph.D., Assistant Professor and head Department of 
Pharmaceutical chemistry, Mr. S.V. Arunachalam, M.Pharm., Lecturer, 
Department of Pharmaceutical chemistry, Mrs. S. Gomathi, M.Pharm., Lecturer, 
Department of Pharmaceutical chemistry and Mrs. B. Vasuki, M.Pharm., 
Lecturer, Department of Pharmaceutical chemistry, for their valuable suggestions 
and inspiration. 
  
 My sincere thanks to Dr. V. Sekar, M.Pharm., Ph.D., Professor and Head, 
Department of Analysis, Mr. M. Senthilraja, M.Pharm., Assistant Professor, and 
Mr. S. Jayaseelan, M.Pharm., Assistant Professor, Department of Pharmaceutical 
Analysis for their valuable suggestions. 
 My sincere thanks to Dr. N. Mahadevan, M.Pharm., Ph.D., Professor and 
Head, Department of Pharmacognosy and Mr. P. Balasubramaniam, M.Pharm., 
Lecturer, Department of Pharmacognosy for their valuable suggestions during my 
project work.   
.    I greatly acknowledge the help rendered by Mrs. K. Rani, Office 
Superintendent, Miss. Prabha, Mrs. V. Gandhimathi, M.A., M.L.I.S., Librarian, 
and Mrs. S. Jayakala, B.A., B.L.I.S., Asst. Librarian for their co-operation. 
           I owe my thanks to all the technical and non-technical staff members of the 
institute for their precious assistance and help. 
 Last, but nevertheless, I am thankful to my lovable parents and all my 
friends for their co-operation, encouragement and help extended to me throughout 
my project work. 
 
E. Krishnaveni 
Reg.No:26113092               
 
 
 
  
 
Animal Ethical Committee Clearance Certificate 
 
We, the Undersigned Chairman/Members of the Animal Ethical Committee, 
functioning in JKK Nattraja College of Pharmacy have studied the proposed research 
Subject/Project of E. Krishanveni titled “Chemopreventive and Antioxidant 
Activity of Cichorium intybus Leaves against NDEA induced Hepatocarcinogenesis 
In Wistar Rats” applying for permission for animal usage and hereby give the 
certificate of clearance of approval by this Ethical Committee.  
 
 
 
 
  Signature of the Chairman/ Members of the  
  Animal Ethical Committee  
 Name of the Institution:  
Station : 
Date :    
Seal : 
 
 
 
 
  
 
 
TABLE OF CONTENTS 
 
CHAPTER 
NO. 
TITLE 
PAGE 
NO. 
1 INTRODUCTION 1 
2 REVIEW OF LITERATURE 34 
3 AIM AND OBJECTIVE OF WORK 44 
4 PLAN OF WORK 47 
5 MATERIALS AND METHODS 48 
6 RESULTS AND DISCUSSION 66 
7 CONCLUSION 108 
8 BIBLOGRAPHY 109 
 
  
 
LIST OF ABBREVIATIONS USED 
 
TB Total bilirubin 
FNH Focal nodular hyperplasia 
HCC Hepatocellular cancer 
HBV Hepatitis B virus 
HCV Hepatitis C virus 
NASH Non-alcoholic steatohepatitis 
Gly Glycyrrhizin 
VLB Vinblastin 
VCR Vincristin 
VDS Vindesine 
VRLB Vinorelbine 
NSCLC Non-small cell lung cancer 
HHT Harringtonine and homoharringtonine 
CHR Complete hematologic remission 
CML Chronic myelogenous leukemia 
CA4 Combretastatin A-4 phosphate 
CdK Cyclin- dependent kinases 
NDEA N- nitroso diethylamine 
ROS Reactive oxygen species 
DPPH 2,2-diphenyl-1-picryl hydrazine 
ONOO- Peroxy nitrite anion 
  
CUPRAC Cupric reducing anti oxidant capacity 
AST Aspartate amino transferase 
ALT Alanine amino transferase 
ALP Alkaline phosphatase 
GGT Gama glutamyl transferase 
H2O2 Hydrogen peroxide 
AFP Alfa feto protein 
CEA Carcino embryonic antigen 
TPC Total phenolic content 
TFC Total flavanoid content 
TTC Total tannin content 
TAC Total antioxidant capacity 
CAT Catalase 
SOD Super oxide dismutase 
GSH Reduced glutathione 
LPO Lipid peroxidation 
GPX Glutathione peroxidise 
TP Total protein 
DNA De-oxy ribonucleic acid 
GAE Gallic acid 
GSH-Px Reduced glutathione Peroxide 
CMC Carboxy Methyl Cellulose 
PB Phenobarbital 
SB Serum bilirubin 
ELISA Enzyme Linked Immnuosorbent Assay 
  
MDA Malondialdehyde 
 
  
 
INTRODUCTION 
LIVER 
The liver, the largest organ in the body, predominantly functions as a 
biochemical laboratory where metabolism takes place. It has both endocrine and 
exocrine functions; and is also involved in numerous metabolic activities and acting 
as a storage depot. Once the nutritional substances and other chemicals such as 
drugs, carcinogens etc reach in liver, they are metabolized by hepatic enzymes. The 
organ is located on the right side of the abdomen just beneath the diaphragm in 
human. Liver is a solid organ consisting of several lobes. Each lobe is constituted 
with numerous lobules which are in general hexagonal in shape (Figure 1). The 
center of each lobule is occupied by the central vein and the periphery of the lobule 
is delineated by a close arrangement of hepatic artery, portal vein, and bile duct; 
called “portal triads”. The portal triads appear at the vertices of the hexagonal 
lobules. The vessels generated from the portal triads ramify and distribute along the 
sides of the lobule, and open into the sinusoids which have thin epithelial lining, a 
discontinuous layer of fenestrated endothelial cells. The liver has different types of 
cells. Oval cells are generally found near the portal triad. This rare cell-type has 
been claimed as hepatic stem cells by some researchers (Zamule et al., 2011). 
However, the major cell-type in liver is the polygonal hepatic parenchymal cells 
(hepatocytes). Hepatic lobules are made up of more than 80% hepatocytes which 
have an average size of 25 µ and occupy 70-90% of liver mass, depending on the 
species. They have clear cell membrane; sometimes with two nuclei. They have 
large deposits of glycogen, often with lipid droplets and basophilic materials. They 
  
also contain other cellular organelles such as mitochondria, rough endoplasmic 
reticulum (granular) and smooth endoplasmic reticulum (agranular), golgi apparatus, 
and lysosomes. The hepatocytes are arranged in stacks of anastomosing plates, 
separated by an anastomosing system of sinusoids. One or two cells thick 
hepatocytes appear radiating from central vein towards the periphery. They 
metabolize and excrete into sinusoids or bile canaliculi. They can undergo cell 
division to produce more hepatocytes. Other than the endothelial cells, the liver 
sinusoids contain phagocytic cells derived from monocytes, known as Kupffer cells. 
These macrophages phagocytize particulates and cell debris. Another hepatic cell-
type is known as the into cell. These are adipose or stellate cells.  
Liver undertakes several important functions in our body.  
¾ Produces bile which contains bile salts (sodium glycocholate, sodium 
taurocholate). The bile salts emulsify fats and oils and thus help in the 
digestion of them. 
¾ Involves in carbohydrate and fat metabolism, hemoglobin metabolism and 
lipid synthesis. 
¾ Stores many chemicals such as glycogens, vitamins, minerals and several 
metabolites involves in detoxification and removal of many toxic chemicals, 
including drugs. 
¾ Carcinogens, and various toxins through bile from the body. 
¾ Converts circulating ammonia into urea by urea cycle (Ornithine cycle) and 
thereby reduces ammonia level in blood. 
  
¾ Produces serum proteins such as albumin, clotting factors. 
Figure. 1 
 
Hepatic regenerative capability 
Under normal condition in an adult, liver maintains its size. However, liver 
has the regenerative capacity. Under various stress conditions, liver-size may 
increase. Numerical increase in hepatic cells by rapid cell division (hyperplasia) or 
increase in cell-size (hypertrophy) primarily causes enlargement of the tissue 
(Michalopoulos & DeFrances, 1997). Exposure to high levels of chemical toxicants 
causes increase in liver-size about 2-3 times of its normal size to combat the 
enhanced metabolic pressure exerted by chemical exposure (Michalopoulos & 
  
DeFrances, 1997). By regeneration process liver replaces the necrotic/ dead cells or 
the cells damaged due to toxicity. During hepatic continual regeneration process, the 
increased collagen synthesis and deposition result in fibrosis. This along with further 
continual hepatic cell damage due to various stress conditions cause liver cirrhosis. 
In cirrhosis, liver morphology alters. Scarring and nodularity appear. Normal hepatic 
function suffers and hepatic homeostasis decreases. 
Microanatomy of liver   
Figure. 2 
 
 
 
 
 
Blood drains from the sinusoids into central or centrilobular veins. These then 
join with veins from other lobules, forming larger veins, until eventually they 
become the hepatic veins, which leave the liver and empty in to the inferior vena 
cava. One of the functions of the liver is to secrete bile. It is seen that bile canaliculi 
run between the columns of liver cells. This means that each column of hepatocytes 
has a blood sinusoid on one side and a bile canaliculus on the other. The canaliculi 
join up to from larger bile canals until eventually they form the right and left hepatic 
ducts, which drain bile from the liver.  
  
Lymphoid tissue and a system of lymph vessels are also present in each 
lobule. 
Histology        
The liver is divided into many hepatic lobules. Inflow to the liver involves 
hepatic arteries, which bring oxygenated blood to hepatic tissue, and portal veins, 
which bring nutrients and other compounds absorbed by the GI tract to be processed 
and/or stored in the liver. Outflow also volves two routes – hepatic veins which 
drain into the inferior vena cava and the common hepatic duct which joins the cystic 
duct and empties bile into the duodenum.  
Major characteristics of the liver are portal triads (labeled “portal” in bottom 
left and shown in the middle) and central veins (labeled in bottom left and shown in 
the right).  
The portal triad contains 1) the portal vein, 2) the hepatic artery, and 3) the 
bile duct. Each has its typical appearance. The central vein is lined with endothelial 
cells, with perforations into which the sinusoids empty. 
Figure. 3 
 
 
 
 
 
  
 
 
Figure. 4 
Histology of normal liver 
 
 
                   
 
 
 
 
 
 
 
        The central veins lead to sub lobular veins, which reach collecting veins, 
hepatic veins, and finally the inferior vena cava. The venous outflow of the liver has 
no regard to the organization of the lobules. 
The liver sinusoids are dilated, capillary-like vessels lined by fenestrated, 
discontinuous epithelium (labeled “e”). Interspersed among the endothelial cells are 
  
Kupffer cells (labeled “k”), which are fixed macrophages within the hepatic tissue. 
They have distinct cytoplasm that may enter the sinusoidal lumen and function like 
other macrophages within the body. They also break down damaged red blood cell 
hemoglobin. (http//www.med.unichedu.com) 
There are many spaces between the hepatocytes and sinusoidal epithelial 
cells. They are referred to the space of Disse where exchange between hepatocytes 
and blood flow takes place. 
Figure. 5  Histological structure of liver lobule 
 
Liver cancer 
Cancer 
The body is made up of trillions of living cells. Normal body cells grow, 
divide, and die in anorderly fashion. During the early years of a person's life, normal 
  
cells divide faster to allow the person to grow. After the person becomes an adult, 
most cells divide only to replace 
worn-out or dying cells or to repair injuries. Cancer begins when cells in a part of 
the body start to grow out of control. There are many kinds of cancer, but they all 
start because of out-of-control growth of abnormal cells. Cancer cell growth is 
different from normal cell growth. Instead of dying, cancer cells continue to grow 
and form new, abnormal cells. Cancer cells can also invade (grow into) other tissues, 
something that normal cells cannot do. Growing out of control and invading other 
tissues are what makes a cell a cancer cell. Cells become cancer cells because of 
damage to DNA. DNA is in every cell and directs all its actions. In a normal cell, 
when DNA gets damaged the cell either repairs the damage or the cell dies. In 
cancer cells, the damaged DNA is not repaired, but the cell doesn’t die like it should. 
Instead, this cell goes on making new cells that the body does not need. These new 
cells will all have the same damaged DNA as the first cell does. People can inherit 
damaged DNA, but most DNA damage is caused by mistakes that happen while the 
normal cell is reproducing or by something in our environment. Sometimes the 
cause of the DNA damage is something obvious, like cigarette smoking. But often 
no clear cause is found. In most cases the cancer cells form a tumor. Some cancers, 
like leukemia, rarely form tumors. Instead, these cancer cells involve the blood and 
blood-forming organs and circulate through other tissues where they grow. Cancer 
cells often travel to other parts of the body, where they begin to grow and form new 
tumors that replace normal tissue. This process is called metastasis. It happens when 
the cancer cells get into the bloodstream or lymph vessels of our body. No matter 
where a cancer may spread, it is always named for the place where it started. For 
  
example, breast cancer that has spread to the liver is still called breast cancer, not 
liver cancer. Likewise, prostate cancer that has spread to the bone is metastatic 
prostate cancer, not bone cancer. Different types of cancer can behave very 
differently. For example, lung cancer and breast cancer are very different diseases. 
They grow at different rates and respond to different treatments. That is why people 
with cancer need treatment that is aimed at their particular kind of cancer. Not all 
tumors are cancerous. Tumors that aren’t cancer are called benign. Benign tumors 
can cause problems – they can grow very large and press on healthy organs and 
tissues. But they cannot grow into (invade) other tissues. Because they can’t invade, 
they also can’t spread to other parts of the body (metastasize). These tumors are 
almost never life threatening. 
Liver cancer 
Liver cancer is a cancer that starts in the liver. These different types of cells 
in the liver can form several types of malignant (cancerous) and benign (non-
cancerous) tumors. These tumors have different causes, are treated differently, and 
have a different prognosis (www.cancer.org/cancer/livercancer). 
Benign liver tumors 
Benign tumors sometimes grow large enough to cause problems, but they do 
not grow intonearby tissues or spread to distant parts of the body. If they need to be 
treated, the patient can usually be cured with surgery. 
Hemangioma 
  
The most common type of benign liver tumor, hemangiomas start in blood 
vessels. Most hemangiomas of the liver cause no symptoms and do not need 
treatment. But some may bleed and need to be removed surgically. 
  
 
Hepatic adenoma 
Hepatic adenoma is a benign tumor that starts from hepatocytes (the main 
type of liver cell). Most cause no symptoms and do not need treatment. But some 
eventually cause symptoms, such as pain or a mass in the abdomen (stomach area) 
or blood loss. Because there is a risk that the tumor could rupture (leading to severe 
blood loss) and a small risk that it could eventually develop into liver cancer, most 
experts usually advise surgery to remove the tumor if possible. The use of certain 
drugs may increase the risk of getting these tumors. Women have a higher chance of 
having one of these tumors if they take birth control pills, although this is rare. Men 
who use anabolic steroids may also develop these. Adenomas may shrink when the 
drugs are stopped. 
Focal nodular hyperplasia 
Focal nodular hyperplasia (FNH) is a tumor-like growth made up of several 
cell types (hepatocytes, bile duct cells, and connective tissue cells). Although FNH 
tumors are benign, it can be hard to tell them apart from true liver cancers, and 
doctors sometimes remove them when the diagnosis is unclear. If you have 
symptoms from an FNH tumor, it can be removed with surgery. Both hepatic 
adenomas and FNH tumors are more common in women than in men. 
Cancers that start in the liver 
Several types of cancer can start in the liver. 
  
 
Hepatocellular carcinoma (hepatocellular cancer) 
This is the most common form of liver cancer in adults. It is also sometimes 
called hepatoma. About 4 of 5 cancers that start in the liver are this type. 
Hepatocellular cancer (HCC) can have different growth patterns: 
¾ Some begin as a single tumor that grows larger. Only late in the disease does 
it spread to other parts of the liver. 
¾ A second type seems to start as many small cancer nodules throughout the 
liver, not just a single tumor. This is seen most often in people with cirrhosis 
(chronic liver damage) and is the most common pattern seen in the United 
States. 
Under a microscope, doctors can distinguish several subtypes of HCC. Most 
often these subtypes do not affect treatment or prognosis (outlook). But one of these 
subtypes, fibrolamellar, is important to recognize. This type is rare, making up less 
than 1% of HCCs. 
Patients with this type are usually younger than age 35, and the rest of their liver 
is not diseased. This subtype generally has a better outlook than other forms of 
HCC. 
Intrahepatic cholangiocarcinoma (bile duct cancer) 
About 10% to 20% of cancers that start in the liver are intrahepatic 
cholangiocarcinomas. These cancers start in the cells that line the small bile ducts 
(tubes that carry bile to the gallbladder) within the liver. (Most cholangiocarcinomas 
  
actually start in the bile ducts outside the liver.) Although the rest of this document 
deals mainly with hepatocellular cancers, cholangiocarcinomas are often treated the 
same way.  
Angiosarcoma and hemangiosarcoma 
These are rare cancers that begin in cells lining the blood vessels of the liver. 
People who have been exposed to vinyl chloride or to thorium dioxide (Thorotrast) 
are more likely to develop these cancers. See the section "What are the risk factors 
for liver cancer?" Some other cases are thought to be due to exposure to arsenic or 
radium, or to an inherited condition known as hemochromatosis. In about half of all 
cases, no likely cause can be identified. These tumors grow quickly and are usually 
too widespread to be removed surgically by the time they are found. Chemotherapy 
and radiation therapy may help slow the disease, but these cancers are usually very 
hard to treat. 
Hepatoblastoma 
This is a very rare kind of cancer that develops in children, usually in those 
younger than 4 years old. The cells of hepatoblastoma are similar to fetal liver cells. 
About 2 out of 3 children with these tumors are treated successfully with surgery 
and chemotherapy, although the tumors are harder to treat if they have spread 
outside of the liver. 
Secondary liver cancer 
Most of the time when cancer is found in the liver it did not start there but 
has spread (metastasized) from somewhere else in the body, such as the pancreas, 
colon, stomach, breast, or lung. These tumors are named and treated based on their 
  
primary site (where they started). For example, cancer that started in the lung and 
spread to the liver is called lung cancer with spread to the liver, not liver cancer, and 
it is treated as lung cancer. 
Risk factors for liver cancer 
A risk factor is anything that affects your chance of getting a disease, such as 
cancer. 
Different cancers have different risk factors.  Scientists have found several 
risk factors that make a person more likely to develop hepatocellular carcinoma 
(HCC). 
Gender 
Hepatocellular carcinoma is much more common in males than in females. 
Much of this is probably because of behaviors affecting some of the risk factors 
described below. The fibrolamellar subtype of HCC occurs in about equal numbers 
in both sexes. 
Race/ethnicity 
In the United States, Asian Americans and Pacific Islanders have the highest 
rates of liver cancer, followed by American Indians/Alaska Natives and 
Hispanics/Latinos, African Americans, and whites. 
Chronic viral hepatitis 
Worldwide, the most common risk factor for liver cancer is chronic (long-
term) infection with hepatitis B virus (HBV) or hepatitis C virus (HCV). These 
infections lead to cirrhosis of the liver (see below) and are responsible for making 
  
liver cancer the most common cancer in many parts of the world.In the United 
States, infection with hepatitis C is the more common cause of HCC, while in Asia 
and developing countries, hepatitis B is more common. People infected with both 
viruses have a very high risk of developing chronic hepatitis, cirrhosis, and liver 
cancer. HBV and HCV can spread from person to person through sharing 
contaminated needles (such as in drug use), unprotected sex, or childbirth. They can 
also be passed on through blood transfusions, although this is very rare in the United 
States since the start of blood product testing for these viruses. In developing 
countries, children sometimes contract hepatitis B infection from prolonged contact 
with family members who are infected. Of the 2 viruses, infection with HBV is more 
likely to cause symptoms, such as a flu-like illness and a yellowing of the eyes and 
skin (jaundice). But most people recover completely from HBV infection within a 
few months. Only a very small percentage of adults become chronic carriers (and 
have a higher risk for liver cancer). The risk of becoming a chronic carrier is higher 
in infants and small children who become infected. HCV, on the other hand, is less 
likely to cause symptoms. But most people with HCV develop chronic infections, 
which are more likely to lead to liver damage or even cancer. Other viruses, such as 
the hepatitis A virus and hepatitis E virus, can also cause hepatitis. But people 
infected with these viruses do not develop chronic hepatitis or cirrhosis, and are not 
at an increased risk of liver cancer. 
Heavy alcohol use 
Alcohol abuse is a leading cause of cirrhosis in the United States, which in 
turn is linked with an increased risk of liver cancer. 
  
 
Cirrhosis 
Cirrhosis is a disease in which liver cells become damaged and are replaced 
by scar tissue. People with cirrhosis have an increased risk of liver cancer. Most (but 
not all) people who develop liver cancer already have some evidence of cirrhosis. 
There are several possible causes of cirrhosis. Most cases in the United States occur 
in people who abuse alcohol or have chronic HBV or HCV infections. Non-
alcoholic fatty liver disease, a condition in which people who consume little or no 
alcohol develop a fatty liver, is common in obese people. People with a type of this 
disease known as non-alcoholic steatohepatitis (NASH) might go on to develop 
cirrhosis. Certain types of inherited metabolic diseases can cause problems in the 
liver that lead to cirrhosis. Some types of autoimmune diseases that affect the liver 
can also cause cirrhosis. 
Obesity 
Being obese (very overweight) increases the risk of developing liver cancer. 
This is probably because it can result in fatty liver disease and cirrhosis. 
Type 2 diabetes 
Type 2 diabetes has been linked with an increased risk of liver cancer, 
usually in patients who also have other risk factors such as heavy alcohol use and/or 
chronic viral hepatitis. This risk may be increased because people with type 2 
diabetes tend to be overweight or obese, which in turn can cause liver problems. 
  
 
Inherited metabolic diseases 
Certain inherited metabolic diseases can lead to cirrhosis. People with 
hemochromatosis absorb too much iron from their food. The iron settles in tissues 
throughout the body, including the liver. If enough iron builds up in the liver, it can 
lead to cirrhosis and liver cancer. 
Other rare diseases that increase the risk of liver cancer include: 
¾ Tyrosinemia 
¾ Alpha1-antitrypsin deficiency 
¾ Porphyria cutanea tarda 
¾ Glycogen storage diseases 
¾ Wilson disease 
Aflatoxins 
These cancer-causing substances are made by a fungus that contaminates 
peanuts, wheat, soybeans, ground nuts, corn, and rice. Storage in a moist, warm 
environment can lead to the growth of this fungus. Although this can occur almost 
anywhere in the world, it is more common in warmer and tropical countries. 
Developed countries such as the United States and those in Europe regulate the 
content of aflatoxins in foods through testing. Long-term exposure to these 
substances is a major risk factor for liver cancer. The risk is increased even more in 
people with hepatitis B or C infections. 
  
 
Vinyl chloride and thorium dioxide (Thorotrast) 
Exposure to these chemicals raises the risk of angiosarcoma of the liver. It 
also increases the risk of developing cholangiocarcinoma and hepatocellular cancer, 
but to a far lesser degree. Vinyl chloride is a chemical used in making some kinds of 
plastics. Thorotrast is a chemical that in the past was injected into some patients as 
part of certain x-ray tests. When the cancer-causing properties of these chemicals 
were recognized, steps were taken to eliminate them or minimize exposure to them. 
Thorotrast is no longer used, and exposure of workers to vinyl chloride is strictly 
regulated. 
Anabolic steroids 
Anabolic steroids are male hormones used by some athletes to increase their 
strength and muscle mass. Long-term anabolic steroid use can slightly increase the 
risk of hepatocellular cancer. Cortisone-like steroids, such as hydrocortisone, 
prednisone, and dexamethasone, do not carry this same risk. 
Arsenic 
Drinking water contaminated with naturally occurring arsenic, such as that 
from some wells, over a long period of time increases the risk of some types of liver 
cancer. This is more common in parts of East Asia, but it might also be a concern in 
some areas of the United States. 
  
 
Factors with uncertain, controversial, or unproven effects on liver cancer risk 
Birth control pills 
In rare cases, birth control pills, also known as oral contraceptives, can cause 
benign tumors called hepatic adenomas. But it is not known if they increase the risk 
of hepatocellular cancer. Some of the studies that have looked at this issue have 
suggested there may be a link, but most of the studies were not of high quality and 
looked at types of pills that are no longer used. Current birth control pills use 
different types of estrogens, different estrogen doses, and different combinations of 
estrogens with other hormones. It is not known if the newer pills increase liver 
cancer risk. 
Tobacco use 
Some studies have found a link between smoking and liver cancer, but this 
has been hard to study because people who smoke are also more likely to drink 
alcohol. The link between smoking and liver cancer seems to be strongest among 
people with viral hepatitis or who drink a lot of alcohol. 
Although several risk factors for hepatocellular cancer are known, exactly 
how these factors cause normal liver cells to become cancerous is only partially 
understood. Cancers develop when the DNA of cells is damaged. DNA is the 
chemical in each of our cells that makes up our genes – the instructions for how our 
cells function. We usually look like our parents because they are the source of our 
DNA. But DNA affects more than how we look. Some genes have instructions for 
controlling when cells grow, divide into new cells, and die. Genes that help cells 
  
grow and divide are called oncogenes. Genes that slow down cell division or cause 
cells to die at the right time are called tumor suppressor genes. Cancers can be 
caused by DNA changes that turn on oncogenes or turn off tumor suppressor genes. 
Several different genes usually need to have changes for a cell to become cancerous. 
Certain chemicals that cause liver cancer, such as aflatoxins, are known to damage 
the DNA in liver cells. For example, studies have shown that aflatoxins can damage 
the TP53 tumor suppressor gene, which normally works to prevent cells from 
growing too much. Damage to the TP 53 gene can lead to increased growth of 
abnormal cells and formation of cancers. Infection of liver cells with hepatitis 
viruses can also damage DNA. These viruses have their own DNA, which carries 
instructions on how to infect cells and produce more viruses. In some patients, this 
viral DNA can insert itself into a liver cell's DNA, where it may affect the cell's 
genes. But scientists still don't know exactly how this might lead to cancer. 
Although scientists are starting to understand how liver cancer develops, much more 
must be learned. Liver cancer clearly has many different causes, and there are 
undoubtedly many different genes involved in its development. It is hoped that a 
more complete understanding of how liver cancers develop will help doctors find 
ways to better prevent and treat them. 
Signs and symptoms of liver cancer 
Signs and symptoms of liver cancer often do not show up until the later 
stages of the disease, but sometimes they may show up sooner. If you go to your 
doctor when you first notice symptoms, your cancer might be diagnosed earlier, 
when treatment is most likely to be helpful. Some of the most common symptoms of 
liver cancer are: 
  
 
¾ Weight loss (without trying) 
¾  Loss of appetite 
¾ Feeling very full after a small meal 
¾  Nausea or vomiting 
¾ Fever 
¾ An enlarged liver, felt as a mass under the ribs on the right side 
¾ An enlarged spleen, felt as a mass under the ribs on the left side 
¾ Pain in the abdomen or near the right shoulder blade 
¾ Swelling or fluid build-up in the abdomen 
¾ Itching 
¾  Yellowing of the skin and eyes (jaundice) 
¾  Enlarged veins on the belly that become visible through the skin. 
¾ Many of the signs and symptoms of liver cancer can also be caused by other 
conditions, including other liver problems.  
¾ Some liver tumors make hormones that act on organs other than the liver. 
These hormones may cause: 
• High blood calcium levels (hypercalcemia), which can cause nausea, 
confusion, constipation, weakness, or muscle problems 
  
• Low blood sugar levels (hypoglycemia), which can cause fatigue or fainting 
•  Breast enlargement (gynecomastia) and/or shrinking of the testicles in men 
•  High counts of red blood cells (erythrocytosis) which can cause someone to 
look red and flushed 
•  High cholesterol levels. (www.cancer.org/cancer/livercancer) 
Herbal medicine 
Herbal medicine is still the mainstay of about 75 - 80% of the world 
population, mainly in the developing countries, for primary health care (Kamboj, 
2000). This is primarily because of the general belief that herbal drugs are without 
any side effects besides being cheap and locally available (Gupta and Raina, 1998). 
According to the World Health Organization (WHO), the use of herbal remedies 
throughout the world exceeds that of the conventional drugs by two to three times. 
The use of plants for healing purposes predates human history and forms the origin 
of much modern medicine. Many conventional drugs originated from plant sources: 
a century ago, most of the few effective drugs were plant based. Examples include 
aspirin (willow bark), digoxin (from foxglove), quinine (from cinchona bark), and 
morphine (from the opium poppy) (Vickers and Zollman, 1999). 
Medicinal Plants with anticancer properties 
The isolation of the vinca alkaloids, vinblastine (1) and vincristine (2) from 
the Madagascar periwinkle, Catharanthus roseus G. Don. (Apo-cynaceae) 
introduced a new era of the use of plant material as anticancer agents. They were the 
first agents to advance into clinical use for the treatment of cancer (Cragg and 
  
Newman, 2005). Vinblastine and vincristine are primarily used in combination with 
other cancer chemotherapeutic drugs for the treatment of a variety of cancers, 
including leukemias, lymphomas, advanced testicular cancer, breast and lung 
cancers, and Kaposi’s sarcoma (Cragg and Newman, 2005). 
Camptotheca acuminate 
Camptotheca acuminata is a Chinese ornamental tree belonging to the family 
Nyssaceae. Camptothecin is an alkaloid that possess anticancer activity and has been 
extracted from the stem wood of Camptotheca acuminate, also known as ‘tree of 
joy’. The first generation analogues of Camptothecin is hycamptin and camptosar 
that are used for the treatment of ovarian and colon cancers (Saltz et al., 2000). The 
major disadvantage in the use of Camptothecin analogues in clinical studies is a 
marked loss of therapeutic activity just due to their intrinsic instabilities that is 
resulting from the rapid hydrolysis of the lactone ring. Camptothecin is a member of 
the quinoline alkaloid group. Camptothecin occurs in different plant parts like the 
roots, twigs and leaves. It also consists of pentacyclic ring structure. The pentacyclic 
ring structure is to be essential for the anticancer activity but recently it has been 
reported that it is not essential for its activity. Camptothecin is selectively cytotoxic 
to S-phase cells, it arrests cells in the G-2 phase and induces fragmentation of 
chromosomal DNA.It shows anticancer activity mainly for solid tumours. 
comptothecin inhibits DNA topoisomerase1 (Redinbo et al., 1998). It shows 
anticancer activity mainly against colon and pancreatic cancer cells. But the 
analogues of comptothecin shows anticancer activity in breast, liver and prostate etc. 
Camptothecin was approved by the US Food and Drug administration in the 1970s 
against colon carcinoma (Moertel et al., 1972). 
  
 
Taxus brevifolia 
Taxus is a small coniferous trees or shrubs belonging to the family Taxaceae. 
The various species of Taxus has been found to possess anticancer agent i.e. Taxol 
(Generic name Paclitaxel and trade name Taxol). Taxol is a complex 
polyoxygenated diterpenoid isolated from the pacific yew, Taxus brevifolia. It was 
discovered in the late 1960s as an antineoplastic agent. Later on, it was isolated from 
several other species of Taxus including Taxus wallichiana.the Himalayan yew. So 
far, more than 300 taxoids have been isolated and characterized from different 
species of Taxus . Taxol as a drug has been developed by the National Cancer 
Institute USA. It has been used for the treatment of refractory ovarian cancer, 
metastatic breast and lung cancer and Kaposi’s sarcoma. It has a basic pentadecane, 
tetracyclic ring system. It has an N-benzoyl-B-phenylisoserine side chain and this 
side chain is essentially required for anticancer activity. Taxol exhibits a unique 
mode of action. It acts as a microtubulin stabilizing agent while the other anticancer 
agents destabilize this process. Taxol is also referred as ‘spindle poison (Wani et al., 
1971) 
Combretum caffrum 
Combretum caffrum is a South African tree belonfing to the family 
combretaceae. The bark of this plant possesses anticancer agent i.e. Combrestatins. 
They are mitotic agents and have been isolated from its bark. It is found to be a 
potent cytotoxic agent which strongly inhibits the polymerization of brain tubulin by 
binding to the colchicines site. CA-4 is the most potent cytotoxic agent that possess 
cytotoxic activity against a wide variety of human cancer cell. CA-4 is thus an 
  
attractive lead molecule for the development of anticancer drugs. Pettit et al., 1985 
reported the isolation and structure of Combrestatin from the bark of African willow 
tree Combretum caffrum. Chemically, they are stilbene derivatives having two 
phenyl rings separated by a C-C double bond. Trimethoxy benzene moiety is 
essential for its activity. The compound is active against colon, lung and leukemia 
cancers. It is stated about this molecule that it is the most cytotoxic phytomolecule 
isolated so far. In vitro studies have shown that CA-4 competes with colchicines for 
binding sites on tubulin. Hence; it is a member of the colchicines-like inhibitors of 
microtubulin assembly than vinca-alkaloid type compound. It is one of a new class 
of anticancer agent that acts by attacking a tumor’s blood supply (Chaplin et al., 
1999). CA-4 has shown a new mode of action by targeting on vascular system. The 
main problem arise with this class of compounds is its poor water solubility. 
Podophyllum peltatum Linnaeus 
Podophyllum peltatum Linnaeus also known as American podophyllum, 
commonly known as the American mandrake or may apple  is a North American 
plant belonging to the family combretaceae and it possess two naturally occurring 
aryl tetralin lignans i.e. Podophyllotoxin and deoxypodophyllotoxin and due to this 
they possess anticancer activity. They were first isolated by Podwyssotzki in 1880. 
Podophyllotoxin was isolated from several other species like P.emodi wall (Indian 
podophyllum) and P.pleianthum (Taiwanese podophyllum).It is a potent cytotoxic 
agent. Two of the semi synthetic derivatives of podophyllotoxin, i.e. etoposide and 
teniposide are currently used in frontline cancer chemotherapy against various 
cancers. It is an aryltetralin lignin, having a lactones ring. It is effective in the 
treatment of wilms tumours, various genital tumours and in non-Hodgkin and other 
  
lymphomas and lung cancer. The attempts to use podophyllotoxins in the treatment 
of human neoplasia were mostly unsuccessful due to complicated side effects such 
as nausea, vomiting, damage of normal tissues etc. Extensive structure modifications 
were performed to obtain more potent and less toxic anticancer agents, which 
resulted in two semi synthetic glucosidic cyclic acetals of epipodophyllotoxin, 
etoposide and teniposide. These are the most widely used derivatives for the 
treatment of lymphomas, acute leukaemia, testicular cancer, ovarian, bladder, and 
brain cancers etc. Podophyllotoxin acts as an inhibitor of assembly of microtubules 
and arrests the cell cycle in metaphase (O’Dwyer et al., 1985) 
Saussurea lappa Clarke 
S.lappa is a perennial herb belongs to family Compositae and it is indigenous 
to India and Pakistan, it grows in the Himalayas at 2500-3500 m elevations. The 
dried roots of S.lappa, called costus roots are used in the traditional system of 
medicine for the treatment of cancer. Sesquiterpene lactones are the most common 
constituents of S. lappa. Sesquiterpenes exert their antitumor activity by triggering 
apoptosis in human leukemia cells. A thorough literature survey indicated that 
Sesquiterpenes lactones are rich in costus roots of which (+)-costunolide (Okugawa 
et al., 1999) is the chief constituent, which has shown potent anticancer activity and 
has been considered as a potential candidate for various types of tumours. The 
compounds extracted includes B-cyclocostunolide, dihydro costunolide and dehydro 
costuslactone.It has been found that exo-methylene group on lactone part of the 
sesquiterpenes is required for eliciting cytotoxicity. It is used against colon cancer, 
skin cancer, breast cancer and lung cancer. 
  
 
Cymbopogon flexuous 
C .flexuosus belongs to family Poaceae. The essential oil from a lemon grass 
variety of C.flexuosus is used for its cytotoxic activity. The oil has a promising 
anticancer activity and causes loss in tumors cell viability by activating the apoptotic 
process. C. flexuosus oil is also thought to help with stress related disorders and has 
been shown to have antifungal and antimicrobial properties (Skehan P et al., 
1990).The various constituents present in the oil are geraniol, geranyl acetate, alpha-
bisabolol and isointermedeol have been individually reported for their cancer cell 
cytotoxicity.The limonene and borneol present in C .flexuosus oil are known for 
their immune stimulatory activity, analgesic and anesthetic activities respectively. A 
successful anticancer drug should kill or incapacitate cancer cells without causing 
excessive damage to normal cells. This ideal situation is achieved by inducing 
apoptosis in cancer cells, which is achieved by using the oil of C .flexuosus. The oil 
shows significant cytotoxic activity against colon cancer, neuroblastoma, Hep-g-
2(liver) and cervix cancer. 
Litchi chinensis 
Litchi chinensis is an exotic fruit belonging to the family sapindaceae. This 
plants generally found in South East Asia, especially in China. Litchi pericarp 
tissues comprise of significant amount of flavanoids [Zhang et al., 2000]. Flavanoids 
play important pharmacological roles against diseases such as cardiovascular 
diseases ,cancer, inflammation and allergy. Epicatechin,proanthocyanidin B2 and 
proanthocyanidin B4 fractions were isolated from the plant and possess cytotoxic 
activity against breast cancer. Isoflavone daidzein could stimulate murine non 
  
specific, activate humoral immunity and enhance cell mediated immunity. A 
reduced risk of breast cancer incidence has been associated with a high intake of 
genistein and moderate consumption of red wine. Wang et al., has reported the 
anticancer activity of Litchi fruit pericarp against human breast cancer and 
hepatocellular carcinoma. A number of studies have suggested that flavanoids play a 
protective role in preventing breast cancer.  Rodgers and Grant suggested that the 
possible mechanisms responsible for anti-breast cancer prevention by flavanol and 
flavanol might involve in metabolizing enzymes that alter metabolic activation of 
potential carcinogens (Rodgers et al., 1998).  
Myrica gale L. 
Myrica gale L., a native plant from Canada, belongs to family Myricaceae is 
used in traditional medicine. Myrica gale L., known commonly as myrique baumier 
and sweet gale, is an aromatic shrub with broad geographical distribution at higher 
latitudes. Myrcene, limonene, alpha-phellandrene and betacaryophyllene were the 
major components isolated from this plant. The anticancer activities of these extracts 
were assessed against human lung carcinoma cell line and human colon 
adenocarcinoma cell line. Ethanobotanical studies indicate that the infusion of 
leaves and fruits of Myrica gale is widely used to treat stomach and cardiac 
disorders too. Myrica gale essential oil extracts shows anticancer activity against 
human lung carcinoma and colon adenocarcinoma (Halim et al., 1973). 
Sesquiterpenes are responsible for the activity of Myrica gale essential oil. Indeed 
alpha-humulene and farnesol are active against most tumor cell lines. 
  
 
Platycodon grandiflorum 
The roots of Platycodon grandiflorum which belongs to the family 
Campanulaceae and has been used in traditional medicine. The extracts from 
Platycodon grandiflorum have been reported to have a wide range of health benefits. 
In particular, in Korea, the roots grown for 4 years to treat bronchitis, asthma, 
pulmonary tuberculosis, diabetes and inflammatory diseases (Takagi et al., 1972). 
Some active compounds, such as triterpenoid and saponin have been identified. Its 
petroleum ether extract exhibits strong inhibitory activity against human cancer cell. 
Growth and the activity of the organic extract has been reported to be greater than 
that of the aqueous extract. Platycodon grandiflorum contains a strong 
polyacetylenic anticancer compound, which exhibited cytotoxicity on the human 
cancer cell lines. 
Liquorice 
Glycyrrhiza (Liquorice) consists of dried, peeled and unpeeled, roots and 
stolon of Glycyrrhiza glabra Linn., belonging to the family Leguminosae. The 
liquorice plant is a legume (related to beans and peas), native to southern Europe 
and parts of Asia. Sophora flavescens, a perennial herb, is a species of plant in the 
genus Sophora belongs to the family papilionaceous. It is a traditional Chinese 
medicine. Matrine (Mat), a component extract from Sophora flavescens Ait. Has a 
wide spectrum of pharmacological activities. Glycyrrhizin (Gly), a major active 
constituent of liquorice (Glycyrrhiza glabra) root has various pharmacological 
effects. Glycyrrhizinic acid is a glycoside and on hydrolysis yields glycyrrhetinic 
acid, which has a triterpenoid structure. Gly and Mat is ancillary drug used clinically 
  
in china for protection of liver function and treatment of tumors. Combined use of 
Gly and Mat could offer better liver protection and anti hepato carcinogenic effects 
than Gly or Mat alone, and whether it could reduce the adverse effects of Glyalone 
by acetaminophen induced hepatotoxicity, diethylnitrosamine–induced 
hepatocarcinogenesis (Wan Xu-Ying et al., 2009, Ma et al., 2008, Shen et al., 
2005).Glycyrrhizin (Gly) molecular formula: (C42H24N2O), a triterpene glycoside 
and a conjugative compound of enoxolone and glucuronic acid as an active 
component of liquorice has been used in preventation of liver cancer (Isbrucker and 
Burdock 2006, Kurisu et al., 2008, Bing et al., 2006, Kimura  et al., 2008, Wen               
et al., 2006). 
Plant-Derived Anti-Cancer Agents in Clinical Use 
The first agents to advance into clinical use were the so-called vinca 
alkaloids, vinblastine (VLB) and vincristine (VCR), isolated from the Madagascar 
periwinkle, Catharanthus roseus G. Don. (Apocynaceae), which was used by 
various cultures for the treatment of diabetes. These drugs were first discovered 
during an investigation of the plant as a source of potential oral hypoglycemic 
agents. While research investigators could not confirm this activity, it was noted that 
extracts reduced white blood cell counts and caused bone marrow depression in rats, 
and subsequently it was found that the treatment of mice bearing a transplantable 
lymphocytic leukemia caused life extension. This led to the isolation of VLB and 
VCR as the active agents. More recent semi-synthetic analogues of these agents are 
vinorelbine (VRLB) and vindesine (VDS).  These agents are primarily used in 
combination with other cancer chemotherapeutic drugs for the treatment of variety 
of cancers. VLB is used for the treatment of leukemias, lymphomas, advanced 
  
testicular cancer, breast and lung cancers and Kaposi’s sarcoma and VCR, in 
addition to lymphomas, also shows efficacy against leukemias, particularly acute 
lumphocytic leukemia in childhood. VRLB has shown activity against non-small-
cell lung cancer and advanced breast cancer (Cragg and Newman, 2005).  
Podophyllum species 
The two clinically-active agents, etoposide (VM 26) and teniposide 
(VP 16-213), which are semi-synthetic derivatives of the natural product, 
epipodophyllotoxin (an isomer of podophyllotoxin) is used for the treatment 
of cancer. The Podophyllum species (Podophyllaceae), P. peltatum Linnaeus 
(commonly known as the American mandrake or Mayapple), and P. emodii 
Wallich from the Indian subcontinent, have a long history of medicinal use, 
including the treatment of skin cancers and warts. P. peltatum was used by 
the Penobscot Native Americans of Maine for the treatment of “cancer and 
interest was promoted by the observation in the 1940s that venereal warts 
could be cured by topical application of an alcohol extract of the dried roots 
(called podophyllin). The major active constituent, podophyllotoxin, was 
first isolated in 1880, but its correct structure was only reported in the 1950s. 
Many closely related podophyllotoxin-like lignans were isolated during this 
period, and several of them were introduced into clinical trials, only to be 
dropped due to lack of efficacy and unacceptable toxicity. Extensive research 
at Sandoz Laboratories in Switzerland in the 1960s and 1970s led to the 
development of etoposide and teniposide as clinically effective agents which 
are used in the treatment of lymphomas and bronchial and testicular 
cancers.  
  
A more recent addition to the armamentarium of plant-derived 
chemotherapeutic agents is the class of molecules called taxanes. Paclitaxel  
initially was isolated from the bark of Taxus brevifolia Nutt. (Taxaceae). The 
use of various parts of T. brevifolia and other Taxus species (e.g. T. 
canadensis Marshall, T. baccata L.) by several Native American tribes for 
the treatment of some non-cancerous conditions has been reported, while 
the leaves of T. baccata are used in the traditional Asiatic Indian (Ayurvedic) 
medicine system, with one reported use in the treatment of “cancer”. 
Paclitaxel, along with several key precursors (the baccatins), occurs in the 
leaves of various Taxus species, and the ready semi-synthetic conversion of 
the relatively abundant baccatins to paclitaxel, as well as active paclitaxel 
analogs, such as docetaxel (Taxotere), has provided a major, renewable 
natural source of this important class of drugs. Paclitaxel is used in the 
treatment of breast, ovarian and non-small-cell lung cancer (NSCLC), and 
has also shown efficacy against Kaposi sarcoma. Paclitaxel has also attracted 
attention in the potential treatment of multiple sclerosis, psoriasis and 
rheumatoid arthritis. Docetaxel is primarily used in the treatment of breast 
cancer and NSCLC.  
Another important addition to the anti-cancer drug armamentarium 
is the class of clinically-active agents derived from camptothecin, which is 
isolated from the Chinese ornamental tree, Camptotheca acuminata Decne 
(Nyssaceae), known in China as the tree of joy. Camptothecin (as its sodium 
salt) was advanced to clinical trials by the NCI in the 1970s, but was dropped 
because of severe bladder toxicity. However, extensive research was 
performed by several pharmaceutical companies in a search for more 
  
effective camptothecin derivatives, and Topotecan (Hycamtin), developed by 
SmithKline Beecham (now Glaxo SmithKline), and Irinotecan (CPT-11; 
Camptosar), originally developed by the Japanese company, Yakult Honsha, 
are now in clinical use. Topotecan is used for the treatment of ovarian and 
small-cell lung cancers, while Irinotecan is used for the treatment of 
colorectal cancers. 
Other plant-derived agents in clinical use are homoharringtonine, isolated 
from the Chinese tree, Cephalotaxus harringtonia var. drupacea (Sieb and Zucc.) 
(Cephalotaxaceae), and elliptinium, a derivative of ellipticine, isolated from species 
of several genera of the Apocynaceae family, including Bleekeria vitensis A. C. Sm., 
a Fijian medicinal plant with reputed anti-cancer properties. A racemic mixture of 
harringtonine and homoharringtonine (HHT) has been used successfully in China for 
the treatment of acute myelogenous leukemia and chronic myelogenous leukemia. 
Purified HHT has shown efficacy against various leukemias, including some 
resistant to standard treatment, and has been reported to produce complete 
hematologic remission (CHR) in patients with late chronic phase chronic 
myelogenous leukemia (CML). Elliptinium is marketed in France for the treatment 
of breast cancer (Cragg and Newman, 2005). 
Plant-Derived Anticancer Agents in Clinical Development 
The flavone, flavopiridol is totally synthetic, but the basis for its novel 
structure is a natural product, rohitukine, isolated by chemists at Hoechst 
India Ltd. in the early 1990s from Dysoxylum binectariferum Hook. f. 
(Meliaceae), which is phylogenetically related to the Ayurvedic plant, D. 
malabaricum Bedd., used for rheumatoid arthritis. Rohitukine was isolated 
  
as the constituent responsible for anti-inflammatory and 
immunomodulatory activity. 
The combretastatins were isolated from the South African “bush 
willow”, Combretum caffrum (Eckl. & Zeyh.) Kuntze (Combretaceae).  
Species of the Combretum and Terminalia genera, both of which belong to 
the Combretaceae family, are used in African and Indian traditional 
medicine for the treatment of a variety of diseases, including hepatitis and 
malaria. Several Terminalia species have reportedly been used in the 
treatment of cancer. The combretastatins are a family of stilbenes which act 
as anti-angiogenic agents, causing vascular shutdown in tumors and 
resulting in tumor necrosis. A water-soluble analogue, combretastatin A-4 
phosphate (CA4), has has shown promise in early clinical trials. Of interest is 
the number of combretastatin (CA4) mimics being developed. Three are in 
clinical trials, while 11 are in preclinical development. 
An interesting agent in early clinical development is roscovitine which 
is derived from olomucine, originally isolated from the cotyledons of the 
radish, Raphanus sativus L. (Brassicaceae), but which is now produced 
synthetically. Olomucine stimulated interest as a result of its inhibition of 
cyclin-dependent kinases (Cdk), proteins which play a major role in cell cycle 
progression (Cragg and Newman, 2003). 
  
 
REVIEW OF LITERATURE 
PLANT PROFILE 
 
Botanical name 
Cichorium intybus L. 
Scientific classification 
Kingdom : Plantae 
Subkingdom : Tracheobionta - vascular plants 
Division : Magnoliophyta 
Class : Magnoliopsida 
Order : Asterales 
Family : Asteraceae 
Genus : Cichorium 
  
Species :  C. intybus L 
Vernacular name 
Common chicory, Blue sailors, Succory, Coffeeweed, Cornflower, Wild 
chicory, Wild succory, Garden endive, Garden chicory, Endive. 
Common name: 
Chicory, Blue sailors, Succory, Coffee weed  
• Hindi: Kasni, Hinduba  
• Tamil: Kasni  
• Marathi: Kachani  
• Telugu: Kasini, kasini-vittulu  
• Kannada: Chikory  
• Urdu: Kasni, tukme-e-kasni, barg-e-kasni 
• Sanskrit: Kasni 
DESCRIPTION  
Chicory is a bushy perennial herb with blue or lavender flowers. It is a bushy 
perennial plant that attains a height of 1 to 4 feet. The stem has edges having hard 
branches. Flowers occur either solitary on nearly leafless branches, or in clusters in 
leaf axils. Flower-heads are 2.5-4 cm across, with spreading ray-florets. The green 
bracts below the flowers are prominent. The outer lancelike bracts are spreading 
outwards, while the longer inner ones are upright. Leaves are oblong-lancelike, and 
  
lower leaves are pinnately lobed. The upper leaves are entire, bract-like, stem-
clasping. Root is like a tail of a cow and is fleshy having brownish color from 
outside and white color from inside. It has a length of 2 ½ feet and has a bitter taste. 
Chicory is grown for its leaves, or for the roots, which are baked, ground, and used 
as a coffee substitute in instant coffee. In India Chicory is found in the northwestern 
regions like Kashmir and Punjab and in areas of south India. 
Parts used: Root, herb during blooming period. 
CHEMICAL CONSTITUENTS 
¾ The active compounds in chicory are inulin, sesquiterpene lactones, 
vitamins, minerals, fat, mannitol and latex. Fructans have been extracted 
from chicory roots (Bais and Ravishankar, 2001).  
¾ The postulated biosynthesis of sesquiterpene lactones through the 
mevalonate-farnesyl diphosphate-germacradiene pathway has been 
confirmed by the isolation of a (+)-germacrene A synthase from chicory 
roots (Finke et al., 2002).  
¾ Chemical constituents of Cichorium  intybus L. were identified as alpha-
amyrin, taraxerone, baurenyl acetate and beta-sitosterol (De Kraker et al., 
1998).  
¾ Inulooligosaccharides (IOS) production from chicory extract was carried out 
using endoinulinase obtained from a new isolate, Xanthomonas oryzae No. 5 
(Du et al., 1998).  
  
¾ Twelve compounds were isolated from the root of Cichorium  intybus 
including 2, 3, 4, 9-tetrahydro-1H-pyrido-(3,4-b)indole-3-carboxylic acid 
(Cho et al., 2001).  
¾ The bitter substances are primarily the two sesquiterpene lactones Lactucin 
and Lactucopicrin. Other ingredients are Aesculetin, Aesculin, Cichoriin, 
Umbelliferone, Scopoletin and 6.7-Dihydrocoumarin and further 
sesquiterpene lactones and their glycosides (He et al., 2002).  
Medicinal uses  
The ancient Egyptians ate large amounts of chicory because it was believed 
that the plant could purify the blood and liver, while others have relied on the herb 
for its power to cure "passions of the heart." Chicory continues to be a popular 
herbal remedy due to its healing effects on several ailments. 
Whole plant, especially root, contains volatile oils, which produce high 
toxicity to internal parasites. Chicory is used as a tonic in the treatment of gallstones, 
gastro-enteritis, sinus problems, cuts and bruises. Inulin, the dietary fiber found in 
chicory is a helpful ingredient in treating diabetes and constipation. Chicory is also 
often recommended for jaundice and spleen problems. The juice made of leaves and 
a tea made from the blooming plant help the release of gallstones, elimination of 
internal mucus and production of bile. They are also useful for gastrointestinal 
problems: digestive difficulties, gastritis and lack of appetite. 
Root chicory contains volatile oils similar to those found in plants in the 
related genus Tanacetum which includes Tansy, and is similarly effective at 
  
eliminating intestinal worms. All parts of the plant contain these volatile oils, with 
the majority of the toxic components concentrated in the plant's root.  
Chicory is well known for its toxicity to internal parasites. Studies indicate 
that ingestion of chicory by farm animals results in reduction of worm burdens 
(Häring et al., 2007) which has prompted its widespread use as a forage supplement. 
Only a few major companies are active in research, development, and production of 
chicory varieties and selections, most in New Zealand. 
Chicory (especially the flower) is used as a folk medicine in Germany, is 
recorded in many books as an ancient German treatment for everyday ailments. It is 
variously used as a tonic and as a treatment for gallstones, gastro-enteritis, sinus 
problems and cuts and bruises. Chicory contains inulin (Roberfroid et al., 2002), 
which may help humans with weight loss, constipation, improving bowel function, 
and general health. In rats, it may increase calcium absorption and bone mineral 
density.  
Chicory has demonstrated antihepatotoxic potential in animal studies 
(Tabassum et al., 2010).  
Milala et al., 2009 evaluated composition and properties of cichory extracts 
rich in fructants and polyphenols. The lyophilized extract obtained from cichory 
seeds was the richest in polyphenol compounds and contained over 10% of total 
phenolics, including 71% of dicaffeoylquinic acids, and was characterized by the 
highest antioxidant activity. 
Helal et al., 2011 evaluated effect of Cichorium intybus L on fatty liver 
induced by oxy tetracycline in albino rats .The treatment with cichory ameliorated 
  
most of the evaluated biochemical parameters and improved the induced 
degenerative histopathological changes .The pretreatment with cichory before the 
induction of fatty liver gave some protection against factors that experimentally 
induced fatty liver. 
 Ali, 2012 evaluated antihyperglycemic effect of cichory leaves and 
vanadium consumption on diabetic experimental rats. Vanadium administered in 
combination with cichory was the most effective in controlling the altered glucose 
metabolism and antioxidant status in diabetes rats.  
Kocsis et al., 2003 evaluated effects of cichory on pancreas status of rats in 
experimental dislipidemia .The effects of bioactive molecule of cichory extract 
influenced the lipid metabolism and the redox balance of pancreatic tissue of rat in 
experimental dislipidemia. 
Atta et al., 2010 evaluated hepatoprotective effect of methanol extracts of 
Zingifer officinale and Cichorium intybus. Methanol extract of ginger (250 and 500 
mg/kg) and cichory (250 and 500 mg/kg) given alone or  mixed (1:1 wt/wt) 
significantly restored the  carbon tetra chloride induced alterations in the 
biochemical and cellular constituents of  blood . 
Pillai and Damodhran, 2007 evaluated prevention of radiation-induced 
chromosome damage in mouse bonemarrow by aqueous leaf extract of Cichorium 
intybus. The administration of aqueous leaf extract of cichory to the animals showed 
significant reduction in micronucleus induction .The extract also possessed 
significant hydroxyl radical scavenging activity. The effectiveness of the drug to 
prevent chromosomal damage consequent to irritation along with its high solubility 
  
in water, favour its application in accidental radiation exposures and nuclear 
accidents. 
Jamshidzadeh et al., 2006 evaluated hepatoprotective activity of Cichorium 
intybus L. leaves extract against carbon tetrachloride induced toxicity. The 
Cichorium intybus extract itself was toxic towards isolated hepatocytes in 
concentrations above 3.6 mg/ml .The results of the present study therefore supported 
the traditional believes on hepatoprotective effect of the Cichorium intybus extract, 
however, high concentrations were hepatotoxic. 
Heibatollah et al., 2008 evaluated hepatoprotective effect of Cichorium 
intybus on CCl4 induced liver damage in rats. The leave extract at oral dosage of 
200, 400, and 500 mg/kg  exhibited significant (p<0.05) protective effect against 
CCl4 induced hepatotoxicity.Cichorium intybus extract significantly suppressed 
mainly the increase in plasma acticvities of AST, ALT, ALP and TB concentration 
,which are considered as markers of liver fuctional states. The results of this study 
confirmed the hepatoprotective activity effect of the hydro alcoholic extract of 
Cichorium intybus. 
Naseem et al., 2009 evaluated hepatoprotective effect of Cichorium intybus 
linn  extract against carbon tetrachloride  induced liver damage .Hepatoprotective 
effect  (p<0.001) was observed by alcoholic extract while aqueous extract showed 
no significant effect against CCl4 induced hepatic injury. 
Najafzadeh et al., 2011 evaluated factors related to liver function in serum 
of horse by administration of Cichorium intybus. Cichory does not affect 
concentration of ALT, AST, ALP, LDH, conjugated and total bilirubin, total protein 
  
and albumin and uric acid in serum of horse in normal condition, but it may be 
benefit in pathological conditions. 
Nandagopal et al., 2007 evaluated phytochemical and antibacterial studies 
of cichory. The hexane and ethyl acetate root extracts of cichory showed 
pronounced inhibition than chloroform petroleum ether and water extracts. Root 
extracts showed more inhibitory action on Bacillus subtilis, Staphylococcus aureus 
and Salmonella typhi than Micrococcus luteus and Escherichia coli.   
 Nehal et al., 2011 evaluated hepatoprotective effect of feeding celery leaves 
mixed with cichory leaves and Barley grains to hypercholesteromic rats. Feeding of 
diet supplemented lowered the elevated serum level of liver enzymes and blood 
lipids in rats. While, feeding plant combination of celery, chicory and barley at 15% 
concentration (5% from each) was more effective in decreased the elevating of liver 
enzymes (AST, ALT and ALP), lowered blood lipids.  
Kim et al., 2002 evaluated effects of the ethanol extract of Cichorium 
intybus on the immunotoxicity by ethanol in mice. These findings indicate that the 
immunotoxicity induced by ethanol is significantly restored or prevented by 
Cichorium intybus on the immunotoxicity by ethanol. 
Pushparaj et al., 2007 evaluated anti-diabetic effects of Cichorium intybus 
in streptozotocin-induced diabetic rats. Hypoglycaemic effects of ethanolic extract 
of Cichorium intybus were observed in an oral glucose tolerance test (OGTT) in 
which, a dose of 125mg of plant extract /kg body weight exhibited the most potent 
hypoglycaemic effect. Moreover daily administration of ethanolic extract of 
Cichorium intybus (125mg/kg) for 14 days to diabetic rats attenuated serum glucose 
  
by 20% by, triglycerides by 91% and total cholesterol by 16%. However,there was 
no change in serum insulin levels, which ruled out the possibility that ethanolic 
extract of Cichorium intybus induces insulin secretion from pancreatic β-cells . 
Sultana et al., 1995 evaluated crude extracts of hepatoprotective plants, 
Solanum nigrum and Cichorium intybus inhibit free radical-mediated DNA damage. 
The effect was dependent on the concentration of plant extracts. However, the effect 
of Cichorium intybus was much pronounced as compared to the effect of Solanum 
nigrum.  These studies suggest that the observed hepatoprotective effect of these 
crude plant extracts may be due to their ability to suppress the oxidative degradation 
of DNA in tissue debris. 
Zafar et al., 1998 evaluated anti-hepatotoxic effects of root and root callus 
extracts of Cichorium intybus L. The results revealed that Cichorium intybus root 
callus extracts could afford a better protection against carbon tetrachloride induced 
heptocellular damage as compared to the natural root extract. 
Schmidt et al., 2007 evaluated toxicological evaluation of a cichory root 
extract .There were no treatment–related toxic effects from cichory extract 
administered orally at 70,350, or 1000mg/kg/day. 
Ahmed et al., 2003 evaluated antihepatotoxic activity of seeds of Cichorium 
intybus. The methanol fraction and compound AB-IV were found to possess a potent 
antihepatotoxic activity comparable to the standard drug silymarin (silybon-70). The 
histopathological study of the liver was also carried out, where in the methanolic 
fraction and compound AB-IV showed almost complete normalization of the tissues 
as neither fatty accumulation nor necrosis was observed. 
  
Suntar et al., 2012 evaluated comparative evaluation of traditional 
prescriptions from Cichorium intybus L for wound healing.  Stepwise isolation of an 
active component by in vivo bioassay and its mode of activity. That Cichorium 
intybus roots exerted a prominent wound healing activity and β-sitosterol was 
isolated as at least one of the active component responsible from this effect. 
Jurgonski et al., 2011 evaluated composition of cichory root, peel, seed and 
leaf ethanol extracts and biological properties of their non-inulin fractions. The 
chemical composition of the 75% ethanol extracts of root, peel, leaf and seed 
presented in this study indicates that different parts of cichory and its by–products 
might be good sources of functional compounds (inulin, cichoric acid, quercetin, 
glucuronide, chlorogenic acid and other caffeoylquinic acids. In connection with 
their ability to increase the protection against lipid peroxidation, points that cichory 
non-inulin fractions, rich in phenolics, extracted from leaves and root peels might be 
an additional factor in improving the physiological activity of inulin.   
 
  
 
AIM AND OBJECTIVE 
Liver cancer, especially hepatocellular carcinoma (HCC), is the fifth most 
common cancer and the third foremost cause of cancer associated death globally 
(Befeler and Di Bisceglie, 2002; Bishayee and Dhir, 2009). Hepatocellular 
carcinoma can be secondary to hepatitis B or C, cirrhosis due to alcohol 
consumption, liver disease due to aflatoxin toxicity, hormonal imbalance and certain 
metabolic diseases (Thorgeirsson and Grisham, 2002). Hepatocarcinogenesis 
involves initial genotoxic insult (initiation), clonal expansion from premalignant to 
malignant lesions (promotion) and finally tumor progression by further clonal 
expansion (Thorgeirsson and Grisham, 2002; Halsted et al., 1996).    
 N-Nitrosodiethylamine (NDEA) a potent hepatocarcinogen, is known to 
cause perturbations in the nuclear enzymes involved in DNA repair/replication 
(Bhosale et al., 2002) and is normally used as a carcinogen to induce liver cancer in 
animal models. Investigations have provided evidence that N-nitrosamines cause 
wide range of tumours in all animal species and these compounds are considered to 
be effective health hazards to man (Loeppky, 1994). The main cause for concern is 
that diethylnitrosamine is found in a wide variety of foods like cheese, soybean, 
smoked, salted and dried fish, cured meat and alcoholic beverages (Liao et al., 
2001). Metabolism of certain therapeutic drugs is also reported to produce 
diethylnitrosamine (Akintonwa, 1985). It is also found in tobacco smoke at a 
concentration ranging from 1 to 28 ng/cigarette and in baby bottle nipples at a level 
of 10 ppb (IARC, 1972). It has been reported that, on metabolic activation, it 
produces the pro-mutagenic products, O6-ethyl deoxy guanosine and O4 and O6- 
  
ethyl deoxy thymidine in liver which are responsible for its carcinogenic effects 
(Verna et al., 1996). It is also reported that the generation of reactive oxygen species 
(ROS) by NDEA causes carcinogenic effects. Oxidative stress caused by ROS has 
been reported in membrane lipid peroxidation, DNA damage and mutagenesis 
associated with various stages of tumor formation process (Parola and Robino, 
2001). Human liver appears to metabolize nitrosamines in a manner similar to that 
of rodent liver and also exhibits considerable similarities with regard to morphology, 
genomic alterations and gene expression, despite their different disease etiologies 
(Feo et al., 2000). Hence the model of NDEA-induced HCC is considered as one of 
the most accepted and widely used experimental models to study 
hepatocarcinogenesis (Hai et al., 2001).  
Chemoprevention offers a novel approach to control the incidence of liver 
cancer (Wattenberg and Estensen, 1996). A large number of chemotherapeutic 
agents have been identified in epidemiological and experimental studies, preclinical 
and clinical observations (Takcuji et al., 1993; Jagadeeswaran et al., 2000). 
However, the toxic effects produced by some of the agents have limited their 
extensive use. There is, therefore, a need to identify synthetic or natural compound 
that have significant chemopreventive potential to block initiation or arrest the 
progression in premalignant cells without undesirable side effects. 
In recent years, there has been considerable interest in natural products with 
antioxidant property to protect cellular components from oxidative damage and 
prevent diseases. Over 50 % of anticancer drugs approved by United States Food 
and Drug Administration since 1960 were originated from terrestrial plants (Kim 
and Park 2002; Mann, 2002). Several constituents present naturally in medicinal 
  
plants have been shown to modify critical reactions that cause inhibition of 
chemically induced hepatocarcinogenesis (Soni et al.,1997; Bhattacharya and 
Chattarjee, 1998) and this worldwide effort continues to discover new anticancer 
drugs from plants.  Among the herbal resources is Cichorium intybus Linn.   
Chicory has a long history of herbal use and is especially of great value for 
its tonic effects upon the liver and digestive tract. The root and the leaves are 
appetiser, cholagogue, depurative, digestive, diuretic, hypo-glycemic, laxative and 
tonic. A decoction of the root has been used in the treatment of jaundice, liver 
enlargement, gout and rheumatism. In Indian traditional therapy, chicory was stated 
to possess tonic properties (Chopra et al.,1996). The tonic of chicory was considered 
to be beneficial in the treatment of enlarged spleen and diarrhoea. Studies have 
shown that chicory preparations possessed potent anti-hepatotoxic activity (Chhaya 
and Mishra, 1997). The alcoholic extract of Cichorium intybus is being used to treat 
pyorrhea or gingival inflammation (Patel and Bhatt, 1985). Aqueous and alcoholic 
extracts showed anti-inflammatory activity against formalin-induced oedema. It is 
also reported to have quinidine-like action on isolated heart (Jindal et al.,1975). A 
decoction of the leaves has been used in the treatment of jaundice, liver 
enlargement, gout and rheumatism (Pushparaj et al., 2007). Based on the widespread 
use of Cichorium intybus leaves in liver disorders, a study was planned to evaluate 
the chemopreventive effect of Cichorium Intybus leaves against NDEA induced 
hepatocarcinogenesis in wistar rats. 
 
 
  
 
PLAN OF WORK 
The objective of the present study is 
i. To collect Cichorium intybus plant material and authenticate the plant 
material. 
ii. To prepare extract of Cichorium intybus leaves using solvents of varying 
polarity. 
iii. To determine the presence of various phytoconstituents by qualitative 
analysis. 
iv. To determine the total flavonoid content in various solvent extracts. 
v. To determine the total phenol content in various solvent extracts. 
vi. To determine the total tannin content in various solvent extracts. 
vii. To evaluate the antioxidant and radical scavenging activity of various 
solvent extracts.   
viii. To evaluate the chemopreventive and antioxidant activity of extract 
which showed a potent activity in invitro analysis against N-
nitrosodiethylamine induced hepatocarcinogenesis in wistar rats by 
studying various parameters.  
  
 
MATERIALS AND METHODS 
Plant Material 
 The fresh leaves of Cichorium intybus Linn were collected from 
Vaniyambadi, Tamilnadu, India. The plant material was taxonomically indentified, 
confirmed and authenticated by Botanical Survery of India, Coimbatore, Tamilnadu 
and the voucher specimen (BSI/SRC/5/23/2012-13/Tech-1952) was retained in our 
laboratory for further reference. The collected leaves were shade dried and the dried 
materials were crushed to coarse powder with mechanical grinder. The powder was 
stored in an airtight container for extraction. 
Animals 
 The animals used in this study were obtained from Agricultural University, 
Mannuthy, Thrissur, kerala (328/99/CPCSEA) and were housed in polypropylene 
cages. The animals were maintained under standard laboratory conditions (25° ± 
2°C; 12 hr light and dark cycle). The animals were fed with standard diet and water 
ad libitum. Ethical clearance (for handling of animals and the procedures used in 
study) was obtained from the Institutional Animal Ethical Committee 
(887/ac/05/CPCSEA) before performing the study on animals. 
Extraction of Cichorium intybus leaves 
 The powdered leaves of Cichorium intybus were successively extracted in 
Soxhlet apparatus for 72 hours with solvents of increasing polarity i.e. petroleum 
ether (60-80° C), benzene, chloroform and methanol. After extraction, the solvent 
  
was removed by distillation and evaporated under reduced pressure in a rotary 
evaporator to obtain crude extract. The dried extract thus obtained was stored in air 
tight glass container for further investigation. 
Phytochemical screening 
 The extracts obtained were subjected to preliminary phytochemical screening 
(Kokate, 1994; Rosenthaler, 1930) 
Phytochemical screening 
 Phytochemical examinations were carried out for all the extracts as per the 
standard methods.  
Detection of alkaloids  
 Individually the extracts were dissolved in dilute Hydrochloric acid and 
filtered. The filtered extract was subjected to detection of alkaloids. 
Mayer’s Test 
 Filtrates were treated with Mayer’s reagent (Potassium Mercuric Iodide). 
The formation of a yellow coloured precipitate indicates the presence of alkaloids.  
Wagner’s Test 
 Filtrates were treated with Wagner’s reagent (Iodine in Potassium Iodide). 
The formation of brown/reddish precipitate indicates the presence of alkaloids.  
Dragendroff’s Test 
  
 Filtrates were treated with Dragendroff’s reagent (solution of Potassium 
Bismuth Iodide). The formation of red precipitate indicates the presence of alkaloids.  
Hager’s Test 
 Filtrates were treated with Hager’s reagent (saturated picric acid solution). 
The formation of yellow coloured precipitate indicates alkaloids. 
Detection of carbohydrates 
 The extracts were dissolved individually in 5 ml distilled water and filtered. 
The filtrates were used to test for the presence of carbohydrates.  
Molisch’s Test 
 Filtrates were treated with 2 drops of alcoholic α-naphthol solution in a test 
tube.  The formation of the violet ring at the junction indicates the presence of 
Carbohydrates.  
Benedict’s Test 
 Filtrates were treated with Benedict’s reagent and heated gently. Orange red 
precipitate indicates the presence of reducing sugars.  
Fehling’s Test 
 Filtrates were hydrolysed with dil HCl, neutralized with alkali and 
heated with Fehling’s A & B solutions. The formation of red precipitate 
indicates the presence of reducing sugars.  
Detection of glycosides 
  
 Individually the extracts were hydrolysed with dil. HCl, and then 
subjected to test for glycosides.  
Modified Borntrager’s Test 
 The extracts were treated with Ferric Chloride solution and immersed 
in boiling water for about 5 minutes. The mixture was cooled and extracted 
with equal volumes of benzene. The benzene layer was separated and treated 
with ammonia solution. Formation of rose-pink colour in the ammonical 
layer indicates the presence of anthranol glycosides.  
Legal’s Test  
 The extracts were treated with sodium nitropruside in pyridine and 
sodium hydroxide. The formation of pink to blood red colour indicates the 
presence of cardiac glycosides.  
Keller Killiani Test 
 Small portion from the extract was shaken with 1ml of Glacial acetic acid 
containing trace of ferric chloride. 1ml of Conc H2So4 was added carefully by the 
sides of the test tube. A blue colour in the acetic acid layer and red color at the 
junction of two liquids indicate the presence of glycosides. 
Detection of saponins  
Froth Test 
 Extracts were diluted with distilled water to 20ml and this was shaken 
in a graduated cylinder for 15 minutes. Formation of 1 cm layer of foam 
indicates the presence of saponins.  
  
  
 
Foam Test 
 0.5 gm of extract was shaken with 2 ml of water. If foam produced 
persists for ten minutes it indicates the presence of saponins.  
Detection of phytosterols  
Libermann’s Test 
 To 2ml filtrate in hot alcohol, few drops of acetic anhydride was added. 
Formation of brown precipitate indicates the presence of sterols. 
Salkowski’s Test  
 Extracts were treated with chloroform and filtered. The filtrates were 
treated with few drops of Conc. Sulphuric acid, shaken and allowed to stand. 
Appearance of golden yellow colour indicates the presence of triterpenes.  
Libermann Burchard’s test 
 Extracts were treated with chloroform and filtered. The filtrates were 
treated with few drops of acetic anhydride, boiled and cooled. Conc. 
Sulphuric acid was added. Formation of brown ring at the junction indicates 
the presence of phytosterols.  
Detection of phenols  
Ferric Chloride Test  
 Extracts were treated with 3-4 drops of ferric chloride solution. Formation of 
bluish black colour indicates the presence of phenols.  
  
Detection of tannins  
Lead acetate Test 
 To 2ml of filtrate, few drops of lead acetate solution were added in a test 
tube. Formation of yellow precipitate indicates the presence of Tannins. 
Detection of flavonoids  
Alkaline Reagent Test  
 Extracts were treated with few drops of sodium hydroxide solution. 
Formation of intense yellow colour, which becomes colourless on addition of dilute 
acid, indicates the presence of flavonoids.  
Detection of proteins and aminoacids  
Millon’s Test 
 2ml of filtrate was treated with 2ml of millon’s reagent in a Test tube and 
heated in a water bath for 5 minutes, cooled and few drops of NaNo2 was added. 
Formation of white precipitate, which turns to red upon heating, indicates the 
presence of proteins and amino acids. 
Ninhydrin Test 
 To the extract, 0.25% w/v ninhydrin reagent was added and boiled for few 
minutes. Formation of blue colour indicates the presence of amino acid.  
  
 
Biuret Test 
 2ml of filtrate was treated with 2ml of 10% sodium hydroxide in a test and 
heated for 10 minutes. A drop of 7% copper sulphate solution was added in the 
above mixture. Formation of purplish violent indicates the presence of Proteins. 
Detection of Fixed oils and Fats  
Oily Spot Test 
 One drop of extract was placed on filter paper and the solvent was 
evaporated. An oily stain of filter paper indicates the presence of fixed oil. 
Quantitative estimation of bioactive compounds 
Estimation of total phenolic content 
 The total phenolic content was determined spectrophotometrically using the 
Folin–Ciocalteu method. It is based on the oxidation of phenolic groups by 
phosphomolybdic and phosphotungstic acids (FC reagent). This method, based on 
the Slinkard and Singleton, 1977  and the early work of Singleton & Rossi, 1965  is 
a colorimetric oxidation/reduction method for phenolic compounds. A blue colour 
which is the product of metal oxidation, that exhibits a broad light absorption with a 
maximum at 764 nm. The intensity of light absorption is proportional to the 
concentration of phenols  20 μL of the diluted sample was added to 100 μL of 
Folin–Ciocalteu reagent. After 8 min, 300 μL of saturated sodium carbonate solution 
(25%) was added. The absorbance was measured at 764 nm. The calibration curve 
  
was prepared with gallic acid solutions ranging from 10 to 1000 μg/ml, and the 
results are given as gallic acid equivalents (GAE). 
Determination of total tannin content 
 The total tannin content was determined by modified method of 
Polshelttiwar et al., 2007. Different concentrations of extract (0.1 ml) was mixed 
with 0.5 ml of Folin-Denis reagent and followed by 1 ml of Na2Co3 (0.5% w/v) 
solution and distilled water (up to 5 ml). The absorbance was measured at 755 nm 
within 30 min of the reaction aginst the blank. The total tannin in the extract was 
expressed as the equivalent to tannic acid (g TAE/g extract). 
Determination of total flavonoids  
 Flavonoid content was measured using aluminium chloride colorimetric 
method. Various concentrations of extract were mixed with 0.1 ml of 10 % 
aluminium chloride (w/v), 0.1 ml of 1 M potassium acetate and 2.8 ml distilled 
water. The mixture was allowed to stand at room temperature for 30 minutes. The 
absorbance of reaction mixture was measured at 415 nm. Results are expressed as 
mg/g quercetin equivalent (Chang, 2002). 
Evaluation of total antioxidant capacity by phosphomolybdenum method 
 The antioxidant activities of various solvent extracts were evaluated by the 
phosphomolybdenum method according to the procedure described by Prieto et al 
1999. The assay is based on the reduction of Mo (VI) – Mo (V) by the extract. The 
subsequent formation of a green phosphate/Mo (V) complex at acid pH. 0.3 ml 
different concentrations of extract (10μg/ml to 200 μg/ml) were mixed with 3 ml of 
reagent solution (0.6 M sulfuric acid, 28 mM sodium phosphate and 4 mM 
  
ammonium molybdate). 0.3 mL of methanol was used as blank  in place of extracts. 
The tubes were incubated in a boiling water bath at 95°C for 90 min. The 
absorbance of the solution was measured at 695 nm after cooling to room 
temperature. The antioxidant capacity of each sample was expressed as ascorbic acid 
equivalent. 
Determination of free radical scavenging activity  
 DPPH radical scavenging assay 
 Free radical scavenging activity was determined spectrophotometrically 
using the method of Blois, 1958. This method is based on the measurement of the 
reducing ability of antioxidants toward the DPPH radical. Briefly, 100 μl of various 
concentrations of the Cichorium intybus leaf extract (10 μg/ml to 400 μg/ml) in 
methanol were added to 10 ml of a methanol solution of DPPH (1.01.10-2 M). The 
mixture was allowed to stand at room temperature for 30 min in the dark after a 
vigorous shake. The absorbance was measured at 517 nm. The control mixture 
consists of 100 μl of methanol and 10 ml of DPPH solution. The scavenging activity 
on the DPPH radical was calculated as inhibition percentage using the following 
equation: 
% Inhibition = [(AB − AS)/AB] × 100 
 where AB is the absorbance of the control reaction (containing all reagents 
except the test compound), and AS is the absorbance of the test compound. Ascorbic 
acid was used as reference standard. The tests were carried out in triplicate. The 
extract concentration providing 50% inhibition (IC50) was calculated from the graph 
of inhibition percentage plotted against extract concentration. 
  
  
 
Nitric oxide scavenging activity 
 This method is based on principle that sodium nitroprusside in aqueous 
solution at physiological pH spontaneously generate nitric oxide which further 
interacts with oxygen to produce nitrite ion that can be estimated using Griess 
reagent. Scavenger of nitric oxide competes with oxygen leading to reduced 
production of nitrite ion. For experimental, sodium nitroprusside (10 mM) in 
phosphate buffer saline (PBS pH 7.4) was mixed with different concentration of 
extract (10 μg/ml to 1000 μg/ml) dissolved in respective solvent and incubated at 
25°C for 150 minutes. The same reaction mixture without extract but equivalent 
amount of solvent served as control. After incubation period 1.5 ml of the incubated 
solution was removed and diluted with 1.5 ml of Griess reagent (1% sulphanilamide, 
2% phosphoric acid and 0.1% naphthyl ethylene diamine dihydrochloride). The 
absorbance of the chromophore formed during diazotization of the nitrite with 
sulphanilamide and subsequent coupling with naphthyl ethylene diamine was 
measured at 546 nm. Quercetin was used as positive control (Green et al., 1982). 
The tests were carried out in triplicate. The nitric oxide scavenging activity is 
calculated as  
 Scavenging activity = [{C-T/C} X 100]  
 where C = absorbance of control and T = absorbance of test solution.      
Lipid peroxidation inhibitory activity  
 The lipid peroxidation inhibitory activity of the Cichorium intybus leaf 
extracts were determined according to the method of Duh & Yen, 1997. Egg lecithin 
  
(3 mg/ml phosphate buffer, pH 7.4) was sonicated in an ultrasonic sonicator for 10 
min to ensure proper liposome formation. Test samples of Smilax xeylanica leaf 
extract (100 μl) of different concentrations (10 μg/ml to 1000 μg/ml) were added to 
liposome mixture (1 ml). Ferric chloride (10 μl, 400 mM) and L-ascorbic acid (10 
μl, 200 mM) were added to induce lipid peroxidation. After 1 h incubation at 37° C 
the reaction was stopped by adding hydrochloric acid (2 ml, 0.25 N) containing 
trichloroacetic acid (150 mg/ml) and thiobarbutyric acid (3.75 mg/ml). The reaction 
mixture was boiled for 15 min, cooled, centrifuged at 1000 rpm for 15 min and the 
absorbance of the supernatant was measured at 532 nm. Tocopherol was used as 
reference standard. The control was without extract. 
 The scavenging effect was measured using the following equation 
 Scavenging effect (%) = [(A control - A sample) / A control] X 100. 
Cupric ions (Cu2+) reducing antioxidant capacity (CUPRAC assay) 
 By the method of Apak et al., 2004, the cupric reducing antioxidant capacity 
(CUPRAC) was determined. 1 ml of CuCl2 solution (1.0x10-2M), 1 ml ethanolic 
neocuproine solution (7.5x10-3 M) and 1 ml NH4CH3COO (1M, pH 7.0) were added 
to a test tube and mixed. The Cichorium intybus leaf extract at different 
concentrations (10 μg/ml to 1000 μg/ml) was added to the initial mixture to make 
the final volume 4.1 ml and after 1 h, the absorbance was measured at 450 nm 
against a reagent blank. Increased reduction capability is denoted by increased 
absorbance of the reaction mixture. 
Ferric reducing antioxidant capacity  
  
 According to the method described by Oyaizu, 1986 the reducing powers of 
extracts were determined. Different concentrations of Cichorium intybus leaf 
extracts (10 μg/ml to 1000 μg/ml) in 1 ml of distilled water were mixed with 
phosphate buffer (2.5 ml, 0.2 M, pH 6.6) and potassium ferricyanide [K3Fe(CN)6] 
(2.5 mL, 1%). After incubation at 50°C for 20 min 2.5 ml of trichloroacetic acid 
(10%) was added to the mixture and centrifuged at 3000 rpm for 10 min. The 
supernatant layer of the solution (2.5 ml) was mixed with distilled water (2.5 ml) 
and FeCl3 (0.5 ml, 0.1%) and the absorbance was measured at 700 nm. Increased 
absorbance of the reaction mixture indicates increased reducing power. Ascorbic 
acid was used as reference standard.  
Metal chelating activity 
 According to the method of Dinis et al., 1994, the chelation of ferrous ions 
by extracts was estimated. 50 μl of 2 mM Ferric chloride was added to 1 ml of 
different concentrations of the Cichorium intybus leaf extract (10 μg/ml to 1000 
μg/ml). By the addition of 0.2 ml of 5 mM ferrozine solution the reaction was 
initiated. The mixture was allowed to stand at room temperature for 10 min after 
vigorous shaking. The absorbance of the solution was measured at 562 nm. The 
percentage inhibition of ferrozine-Fe2+ complex formation was calculated as [(A 
control- A- sample)/ A- sample] ´X 100, where A- control denotes absorbance of the 
control, and A- sample denotes absorbance of the extract/ standard. Na2EDTA was 
used as positive control. 
Acute oral toxicity study of chloroform extract of cichorium intybus leaf extract 
Animals:  
  
             Swiss albino mice of female sex weighing 20-25 gms were used for the 
study. The animals were housed in polypropylene cages. The animals were 
maintained under standard laboratory conditions (25º ± 2ºC; 12hr light and dark 
cycle). The animals were fed with standard diet and water ad libitum. Ethical 
clearance (for handling of animals and the procedures used in study) was obtained 
from the Institutional Animal Ethical Committee before performing the study on 
animals. 
Acute Toxicity Test: 
             Acute oral toxicity study for chloroform extract of cichorium intybus was 
carried out as per OECD guideline 425 (Up and Down procedure). The test 
procedure minimizes the number of animals required to estimate the acute oral 
toxicity. The test allows the observation of signs of toxicity and can also be used to 
identify chemicals that are likely to have low toxicity. 
            Animals were fasted (food but not water was with held overnight) prior to 
dosing. The fasted body weight of each animal was determined and the dose was 
calculated according to the body weight. 
Limit Test at 2000 mg/kg 
               The drug was administered in the dose of 2000 mg/kg body weight orally 
to one animal. If the test animal survived, then four animals were dosed 
sequentially; therefore, a total of five animals were tested. Animals were observed 
individually at least once during the first 30 minutes after dosing, periodically 
during the first 24 hours (with special attention given during the first 4 hour), and 
daily thereafter, for a total of 14 days. After the experimental period, the animals 
  
were weighed and humanely killed and their vital organs including heart, lungs, 
liver, kidneys, spleen, adrenals, sex organs and brain were grossly examined 
(OECD, 425) 
Evaluation of chemopreventive and antioxidant activity of chloroform extract 
of Cichorium intybus leaf extract against N-nitrosodiethylamine induced 
hepatocarcinogenesis  
Experimental design and induction of hepatocellular carcinoma (HCC) 
 Healthy male albino wistar rats (6-8 weeks) weighing 130-150 gms were 
used for the study. Randomization in selection of animals for grouping was carried 
out to avoid statistical difference in the body weight of animals. The experimental 
animals were divided into six groups, each group comprising of six animals. The 
experimental animals were divided into six groups of six animals each according to 
the following experimental regimen. Group 1 animals served as normal control rats. 
Group 2 animals received Cichorium intybus leaf extract 200 mg/kg/day in 0.5% 
carboxy methyl cellulose (CMC) orally for 16 weeks. Group 3 animals received 
Cichorium intybus leaf extract 400mg/kg/day in 0.5% CMC orally for 16 weeks. 
Group 4 animals received vehicle 0.5% CMC 2ml/kg/day orally started 1 week prior 
to single intraperitoneal injection of  NDEA 200mg/kg and after two weeks recovery 
carcinogenic effect was promoted by Phenobarbital (0.05%, PB). Promoter was 
supplemented to the animals through drinking water up to 14 successive weeks. The 
oral administration of vehicle was continued after NDEA injection throughout the 
experimental period of 16 weeks. Group 5 animals were given Cichorium intybus 
leaf extract 200mg/kg/day in 0.5% CMC orally started1 week prior to the injection 
of NDEA and 2 weeks later the promoter phenobarbitone was incorporated into the 
  
drinking water at the concentration of 0.05% for 14 successive weeks. The oral 
administration of extract was continued for 16 weeks after NDEA injection. Animals 
in group 6 were given Cichorium intybus leaf extract 400mg/kg/day in 0.5% CMC 
orally started 1 week prior to the injection of DENA and 2 weeks later the promoter 
phenobarbitone was incorporated into the drinking water at the concentration of 
0.05% for 14 successive weeks. The oral administration of extract was continued for 
16 weeks after NDEA injection. Body weight was recorded at the end of every week 
for 16 weeks (Singh et al., 2004). 
Sample collection 
 At the end of the experimental period (16 weeks), blood samples were 
collected from retro-orbital plexus under anaesthesia in EDTA tubes and centrifuged 
at 2200×g for 15 min. at 4°C. Plasma samples were stored at -20°C for biochemical 
analysis.  
Biochemical analysis 
 By the method described by Reitman and Frankel, 1957 serum transaminases 
(AST and ALT) were determined. By the method of Kind and King, 1954 Serum 
alkaline phosphatase (ALP) was estimated. By the method described by Malloy and 
Evelyn, 1937 and wooten, 1964 serum bilirubin (SB) and total protein (TB) were 
estimated. According to the method described by Szas, 1976, gamma glutamyl 
transferase (GGT) activity was determined. By using the enzyme immunoassay kit, 
α-feto protein (AFP) and carcinoembryonic antigen (CEA), the tumor markers were 
estimated based on solid phase enzyme linked immunosorbent assay (ELISA) (Sell, 
1978; Macnab, 1978).  
  
 After blood collection animals were sacrificed by cervical decapitation and 
the liver was excised, washed in ice cold saline, blotted to dryness and examined for 
any deductable changes. A portion of liver tissue was then homogenized for 
biochemical assays.  
Preparation of tissue homogenate 
 The liver tissue was weighed and by using 0.025 M Tris–HCl buffer, 10% 
tissue homogenate was prepared at pH 7.5. The clear supernatant after centrifugation 
at 10,000 rpm was used to measure TBARS. By the method described by Folch                          
et al.,1957, the vitamin E level was determined. The tissues were weighed and using 
chloroform–methanol mixture (CHCl3:CH3OH) (2:1; v/v) lipids were extracted from 
tissues. This extract was used for the estimation of vitamin E. The tissues were 
minced and homogenized (10% w/v) in 0.1 M phosphate buffer (pH 7.0) and 
centrifuged for 10 min and the resulting supernatant was used for the estimation of 
non-enzymatic and enzymatic antioxidants. 
Estimation of Lipid peroxidation (LPO) 
By the method described by Ohkawa et al., 1979, the levels of thiobarbituric acid 
reactive substances in the liver was measured. The portion of liver homogenates was 
mixed with 0.2 ml of 8.1% Sodium dodecyl sulphate, 1.5 ml of 20% acetic acid and 
1.5 mL of 0.8% thiobarbituric acid, then the volume was adjusted to 4.0 ml with 
distilled water. With 1.0 ml of distilled water and 5.0 ml of n- butanol and pyridine 
(15:1 v/v) the reaction mixture was extracted and the absorbance was measured in 
organic layer at 532 nm after centrifugation.  
  
 
Estimation of superoxide dismutase (SOD) activity 
 After diluting the 0.5 ml of tissue homogenate with water, 2.5 ml of ethanol 
and 1.5 ml of chloroform were added and mixed for 1 min at 4 °C and centrifuged. 
The supernatant was separated and determined for enzyme activity. Appropriately 
diluted enzyme preparation is mixed with 1.2 ml of sodium pyrophosphate buffer 
(0.025 M, pH 8.3), 0.1 ml of 186 μM PMS, 0.3ml of 30 μM Nitroblue tetrazolium 
(NBT), 0.2 ml of 780 μM NADH, and water in a total volume of 3 ml. By addition 
addition of NADH, the reaction was started. After the reaction, by the addition of 1 
ml glacial acetic acid and incubation at 30°C for 90 seconds, the reaction was 
stopped. With 4 ml of n-butanol, the reaction mixture was stirred vigorously and 
shaken. At 560 nm, the intensity of the chromogen was measured in the butanol 
layer against butanol blank. A system devoid of enzyme served as control (Kakkar et 
al., 1984). 
Estimation of catalase activity 
 0.1 ml of tissue homogenate is mixed with 1.0 ml of 0.01M phosphate buffer 
(pH 7.0), and 0.4 ml of 2M H2O2. By the addition of 2.0 ml of dichromate-acetic 
acid reagent the reaction was stopped (5% potassium dichromate and glacial acetic 
acid were mixed in 1:3 ratio).  The absorbance was measured at 620 nm. Catalase 
activity was expressed as nm of H2O2 consumed/min/mg protein (Sinha, 1972).  
Reduced glutathione (GSH) 
 By the method of Ellman, 1959, GSH was estimated. By using 2 ml of 5% 
Trichloro acetic acid, 0.5 ml of tissue homogenate was precipitated. 1 ml of 
  
supernatant was taken after centrifugation and mixed with 0.5 mL of Ellman’s 
reagent and 3 ml of phosphate buffer. The absorbance of colour developed was 
measured at 412 nm. 
 Ellman’s reagent- 19.8 mg of 5,5’ dithio (bis) nitrobenzoic acid in 100 ml of 
1% sodium citrate). 
Histopathological examination 
 A portion of liver tissue was subjected to histopathological examination. A 
portion is fixed in 10% formalin and embedded in molten paraffin wax and were 
ultra sectioned (5-6 μm thickness). The tissues were stained with hematoxylin and 
eosin (H & E) and were examined under light microscope for histopathological 
changes. 
Statistical analysis 
 Results were expressed as mean ± standard error of mean (SEM). The results 
were analysed for statistical significance by one way ANOVA followed by dunnett’s 
test (Graphpad Software Inc,La Jolla, CA. Trial version ). The criterion for statistical 
significance was set at P < 0.05. 
  
 
RESULTS AND DISCUSSION 
 
Table 1. Percentage extraction yield of powdered leaves of Cichorium intybus in   
different organic 
solvents 
 
 
 
 
 
Solvent Percentage yield (%w/w) 
Petroleum ether 3.68 % 
Chloroform  3.20 % 
Ethyl acetate 3.33 % 
Ethanol 13.18 % 
  
 
Table 2. Qualitative phytochemical screening of various solvent extracts of 
Cichorium intybus leaves 
Phytochemicals Test 
Pet 
ether 
extract 
Chloroform 
extract 
Ethyl 
acetate 
extract 
Ethylalcohol 
extract 
Alkaloids  a. Mayer’s test 
b. Dragendroff’s 
c. Hager’s test 
d. Wagner’s test 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Phytosterols      
and 
Triterpenoids 
a. Leibermann’s test 
b. Leiberman-Burchard 
c. Salkowaski test 
_ 
_ 
_ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Flavonoids  a. Alkaline reagent test _  +  +  + 
Saponins  a. Foam test _  _  _  + 
Proteins 
and Aminoacids 
a. Millon’s test 
b. Ninhydrin test 
c. Biuret test 
_ 
_ 
_ 
_ 
_ 
_ 
+ 
+ 
+ 
+ 
+ 
+ 
Phenolics and 
Tannins 
a. Ferric chloride test 
b. Lead acetate test 
_ 
_ 
+ 
+ 
+ 
+ 
+ 
+ 
Carbohydrate a. Molisch’s test 
b. Fehling’s test 
c. Benedict’s test 
_ 
_ 
_ 
_ 
_ 
_ 
+ 
+ 
+ 
+ 
+ 
+ 
Gylcosides  a. Modified   
Borntrager’s test 
b. Legal’s test 
c. Keller-Killiani test 
_ 
_ 
_ 
_ 
_ 
_ 
+ 
_ 
+ 
+ 
_ 
+ 
 
(+) Present, (-) Absent 
  
Table 3. Total Phenolic content (TPC), Total Tannin content (TTC), Total 
Flavonoid content (TFC) and Total antioxidant capacity (TAC) of the different 
extracts of Cichorium intybus leaves 
Extract TPC 
(μg of 
GAE/mg of 
extract) 
TTC 
(μg of 
TAE/mg of 
extract) 
 
TFC 
(μg of 
quercetin/mg of 
extract) 
TAC 
(μg  of 
ascorbic 
acid/mg of 
extract) 
Petroleum ether 17.07 15.73 124.22 633.30 
Chloroform  51.67 80.88 428.97 1450.59 
Ethyl acetate 34.60 48.74 28.01 104.47 
Ethanol 42.90 64.38 22.67 56.40 
 
Each sample is analysed thrice (n=3)   
Statistical analysis by one-way ANOVA followed by Tukey multiple 
comparison tests.  
Values significantly differ (P<0.0001) from the other extract in same row. 
Total Phenolic content (TPC) is expressed as milligram of gallic acid 
equivalent per gram of sample. Total tannin content (TTC) is expressed as 
milligrams of tannic acid equivalents per gram of dry extract. Total Flavonoid 
content (TFC) is expressed as milligrams of quercetin equivalents per gram of dry 
extract. Total antioxidant capacity is expressed as milligrams of ascorbic acid 
equivalents per gram of dry extract. 
  
 
Table 4. Free radical scavenging activity of different extracts from leaves of 
Cichorium intybus (IC50 (μg/mL expressed as mean ± S.D) 
Extract 
DPPH radical 
scavenging 
(μg/mL) 
Nitric oxide   
scavenging 
(μg/mL) 
Lipid peroxidation
Inhibitory activity 
(μg/mL) 
Petroleum ether > 1000 5.26 19.55 
Chloroform > 1000 4.30 12.37 
Ethyl acetate 169.64 3.71 9.83 
Ethanol 204 81.30 32.57 
Standard 
(Vitamin E) 
6.80 7.08 2.03 
 
IC50 values were expressed as μg/mL concentration (n=3). Lower IC50 values 
indicate    higher radical scavenging activity. Values are significantly different from 
standard; ns-non significant; *P<0.05;**P<0.01;***P<0.001. (ANOVA, followed by 
Dunnett’s test). Ascorbic acid was used as a reference for DPPH radical scavenging 
activity. Quercetin was used as a reference for nitric oxide scavenging activity. 
Tocopherol was used as a reference for Lipid peroxidation inhibitory activity. 
Na2EDTA was used as a reference for metal chelating activity inhibitory activity. 
  
 
Table 5.   Cupric ions (Cu2+) reducing capacity (CUPRAC assay) of 
various solvent extracts of Cichorium intybus leaves. 
Extract CUPRAC 
μg of Trolox/mg of extract 
Petroleum ether 5866.52 
Chloroform 13398.87 
Ethyl acetate 991.617 
Ethanol 549.439 
 
Figure. 6  DPPH scavenging activity 
 
  
 
Figure. 7 Nitric oxide scavenging activity 
                  
 
Figure. 8 Lipid peroxidation inhibitory activity 
 
 
  
  
 
Figure. 9  Ferric reducing antioxidant capacity 
 
Figure. 10 Metal chelating activity 
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Table.6 Acute oral Toxicity study (425) observations. 
 Reflexes 
Corneal Normal 
Eyelid closure Normal 
Righting Normal 
Light Normal 
Auditory and sensory Normal 
Ocular signs 
Lacrimation Nil 
Miosis Nil 
Mydriasis Nil 
Ptosis Nil 
Chromodacryorrhea Nil 
Iritis Nil 
Conjunctivitis Nil 
Salivation 
Saliva secretion Nil 
Piloerection  
Contraction of erectile tissue Nil 
Analgesia 
Decrease in reaction to 
induced pain 
Nil 
Muscle tone 
Hypo or hypertonia Nil 
Git sign 
Solid  dried / watery stool Nil 
Emesis Nil 
Red urine Nil 
Skin 
Oedema  Nil 
  
 
Respiratory blockage in nostril  
Dyspnoea Nil 
Apnoea Nil 
Tachypnea Nil 
Nostril discharge Nil 
Motor activities 
Locomotion Normal 
Somnolence Nil 
Loss of righting 
reflex 
Nil 
Anaesthesia Nil 
Catalepsy Nil 
Ataxia Nil 
Toe walking Nil 
Prostration Nil 
Fasciculation Nil 
Tremor Nil 
Convulsion  
Clonic/tonic/tonic-
clonic convulsion 
Nil 
Asphyxial 
convulsion 
Nil 
Opistotones (titanic 
spasm) 
Nil 
  
 
 
 
 
 
 
Figure. 11 
Effect of Cichorium intybus leaf extract on body weight gain during NDEA 
induced hepatocarcinogenesis in rats 
 
  
 
Fig. 12  Gross morphology of liver 
 
   
   
    
A - Liver of control animal showing normal morphology. B and C - Liver of animal 
dosed with extract alone 200 mg/kg and 400 mg/kg respectively showing normal 
appearance which is indicates nontoxic nature of extract.  D - Liver of group IV 
NDEA induced untreated animals (NDEA control) showing multiple lesions 
(whitish) with almost the entire surface of liver is occupied with abnormal growth. 
E- Liver of NDEA induced group V animals treated with Cichorium Intybus leaf 
extract 200 mg/kg showing marked reduction in damage caused by NDEA. F- Liver 
of rats treated with Cichorium Intybus leaf extract 400 mg/kg showing normal 
  
morphology similar to control animals. No detectable lesions or nodules were noted 
in anterior and posterior surface of treatment groups.   
Table. 7 Relative liver weights of various groups of rats at the end of the study 
(16 weeks) 
GROUP Relative liver weight (g liver/100 g body wt) 
Group I (Control) (0.5%CMC) 2 ml/kg p.o. 2.22 ± 0.01 
Group II (Extract 200mg/kg p.o.)                     a 2.18 ± 0.03 ns 
Group III (Extract 400mg/kg p.o.)                     a 
2.23 ± 0.03 ns 
Group IV (NDEA alone)                     a 
2.95 ± 0.06*** 
Group IV  
(NDEA + Extract 200 mg/kg p.o.) 
                    b 
2.59 ± 0.05*** 
Group IV  
(NDEA + Extract 400 mg/kg p.o.) 
                    b 
2.52 ± 0.04*** 
 
All values are expressed as mean ± S.E.M, n=6 in each group. 
a Values are significantly different from control group; ns-non significant; *P < 0.05; 
**P < 0.01; ***P < 0.001. 
b Values are significantly different from NDEA- induced group; ns-non significant; 
*P < 0.05;   **P < 0.01; ***P < 0.001 (one-way ANOVA followed by Dunnett’s 
test). 
Figure. 13 Relative liver weights of various groups of rats at the end of the study 
(16weeks) 
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Table.8 Effect of Cichorium intybus leaf extract on the activities of marker enzymes in the serum of control and  
experimental groups of rats 
 
GROUP 
AST 
(SGOT) (IU/L) 
ALT (SGPT) 
(IU/L) 
ALP 
(IU/L) 
TB 
(mg/dl) 
TP 
(mg/dl) 
GGT 
(IU/L) 
Group I (Control) 
(0.5%CMC) 
2 ml/kg p.o. 
 
11.47 ± 0.17 
 
110.0 ± 0.92 
 
215.3 ± 3.60 
 
0.52 ± 0.01 
 
7.88 ± 0.21 
 
12.67 ± 0.20 
Group II 
(Extract 200mg/kg p.o.) 
                        a      
12.13 ± 0.20 ns 
                                    a 
111.20 ±  0.85 ns 
                            a 
207.5 ± 3.86 ns  
                     a 
0.51 ± 0.01 ns 
                          a 
8.03 ± 0.20 ns 
                            a 
12.12 ± 0.23 ns 
Group III 
(Extract 400mg/kg p.o.) 
                          a 
11.90 ± 0.37 ns  
                                  a 
108.20 ± 2.04 ns 
                             a 
217.9 ± 3.90 ns 
                          a 
0.52 ± 0.01 ns 
                            a      
7.41 ± 0.17 ns 
                             a 
12.20 ± 0.33 ns 
Group IV (NDEA 
alone) 
                                a 
69.33 ± 0.20 *** 
                                  a 
436.40 ± 10.38 *** 
                              a 
465.80 ± 9.93 *** 
                             a 
1.76 ± 0.09 *** 
                            a 
4.78 ± 0.21 *** 
                               a 
56.38  ± 2.35 *** 
Group IV 
(NDEA + Extract 200 
mg/kg p.o.) 
                                 b 
16.15 ± 0.20 *** 
                                 b 
162.60 ± 3.15 *** 
                                 b 
232.50 ± 6.40 *** 
                             b 
0.70 ± 0.04 *** 
                             b 
5.48 ± 0.17 *** 
                                 b 
23.68 ± 0.90 *** 
Group IV 
(NDEA + Extract 400 
mg/kg p.o.) 
                               b 
12.17 ± 0.46 *** 
                           b 
121.80 ± 1.63 *** 
                                b 
221.5 ± 4.80 *** 
                              b 
0.59 ± 0.03 *** 
                              b 
6.33 ± 0.16 *** 
                                b 
15.22 ± 0.44 *** 
 
All values are expressed as mean ± S.E.M, n=6 in each group. One -way ANOVA followed by Dunnett’s test was used to compare experimental 
groups. 
a Values are significantly different from control group; ns-non significant; *P < 0.05; **P < 0.01; ***P < 0.001. 
b Values are significantly different from NDEA- induced group; ns-non significant; *P < 0.05;   **P < 0.01; ***P < 0.001. 
  
Table. 9 Effect of Cichorium intybus leaf extract on α-feto protein levels (AFP) 
and carcino embryonic antigen (CEA) levels in the serum of control and 
experimental groups of rats. 
GROUP 
α-feto protein 
(AFP) ng/ml 
Carcino embryonic 
Antigen (CEA) ng/ml 
Group I (Control) 
(0.5%CMC) 2 ml/kg p.o. 
0.52 ± 0.03 1.5 ± 0.14 
Group II 
(Extract 200mg/kg p.o.) 
a 
0.51 ± 0.02 ns 
                         a 
1.46 ± 0.15 ns 
Group III 
(Extract 400mg/kg p.o.) 
a 
0.49 ± 0.02 ns 
                        a 
1.62 ± 0.15 ns 
Group IV 
(NDEA alone) 
a 
0.89 ± 0.03*** 
                         a 
5.85 ± 0.14*** 
Group IV 
(NDEA + Extract 200 mg/kg 
p.o.) 
b 
0.71 ± 0.02*** 
                           b 
4.08 ± 0.24 *** 
Group IV 
(NDEA + Extract 400 mg/kg 
p.o.) 
b 
0.59 ± 0.03*** 
                           b 
2.44 ± 0.14 *** 
 
All values are expressed as mean ± S.E.M, n=6 in each group. One -way 
ANOVA followed by Dunnett’s test was used to compare experimental groups. 
a Values are significantly different from control group; n 
s-non significant; *P < 0.05; **P < 0.01; ***P < 0.001. 
b Values are significantly different from NDEA- induced group; ns-non significant; 
*P < 0.05;   **P < 0.01; ***P < 0.001. 
  
Figure. 14 Effect of Cichorium intybus leaf extract on the activities of marker 
enzymes in the serum of control and experimental groups of rats 
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Figure. 15 Effect of Cichorium intybus leaf extract on α-feto protein levels (AFP) 
and carcino embryonic antigen (CEA) levels in the serum of control and 
experimental groups of rats. 
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Table. 10 Effect of Cichorium intybus leaf extract on lipid peroxidation and the status of enzymatic and non-enzymatic antioxidants in 
liver of control and experimental group of animals 
Parameter 
Group I 
(Control) 
Group II 
Extract 
(200mg/kg) 
Group III 
Extract 
(400mg/kg) 
Group IV 
B(a)P 
Group V B(a)P + 
Extract (200mg/kg) 
Group VI B(a)P + 
Extract (400 mg/kg) 
LPO 0.79 ± 0.05                a 
0.75 ± 0.04 ns 
              a 
0.71 ± 0.06 ns 
            a 
1.69 ± 0.15 *** 
            a 
1.08 ± 0.07 *** 
           a 
0.96 ± 0.03 *** 
SOD 2.62 ± 0.13            a 
2.59 ± 0.12ns 
               a 
2.50 ± 0.15ns 
            a 
0.85 ± 0.01*** 
           b 
1.78 ± 0.03 *** 
             b 
2.36 ± 0.12*** 
 
Catalase 
 
1.94 ± 0.11 
              a 
2.01 ± 0.11ns 
             a 
2.02 ± 0.11 ns 
             a 
 0.85 ± 0.11 *** 
                b           
1.14 ± 0.08* 
           b 
1.41 ± 0.09 *** 
 
GSH 
 
2.26 ± 0.07 
              a      
2.23 ± 0.08 ns 
               a 
2.34 ± 0.02 ns 
             a 
  0.91 ± 0.02 *** 
              b 
1.74 ± 0.04*** 
           b 
1.93 ± 0.04 *** 
 
All values are expressed as mean ± S.E.M, n=6 in each group 
a values are significantly different from control group; ns-non significant; *P < 0.05; **P < 0.01; ***P < 0.001. 
bvalues are significantly different from NDEA control group; ns-non significant; *P<0.05;**P<0.01;***P<0.001. (ANOVA, followed by 
Dunnett’s test)
  
Figure. 16 Effect of Cichorium intybus leaf extract on lipid peroxidation and the 
status of enzymatic and non-enzymatic antioxidants in liver of control and 
experimental group of animals 
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Figure. 17 Histopathological image of liver tissues 
    
     
       
  
 
Percentage yield 
The percentage yield of extract obtained from extraction of powdered leaf 
material of Cichorium intybus using solvents of increasing polarity was found to be 
3.68 % w/w using petroleum ether, 3.20 % w/w using chloroform, 3.33 % using 
ethyl acetate and 13.18 % using ethanol as solvent (Table 1). 
Phytochemical study 
 The phytochemical examination of petroleum ether extract revealed the 
presence of alkaloids, chloroform extract revealed the presence of alkaloids, 
flavonoids, phenolics and tannins, phytosterols and triterpinoids.  Ethyl acetate 
extract revealed the presence of alkaloids, phytosterols and triterpinoids,  flavonoids, 
proteins and aminoacids, phenolics and tannins, carbohydrates and glycosides and 
ethanol extract revealed the presence of alkaloids, phytosterols and triterpinoids,  
flavonoids, proteins and aminoacids, phenolics and tannins, carbohydrates, 
glycosides and saponins (Table 2). 
Quantitative estimation of bioactive compounds 
 The total phenolic content was determined spectrophotometrically using 
the Folin–Ciocalteu method and the results were expressed as gallic acid equivalents 
(GAE). The total phenolic content in chloroform extract was found to be high which 
showed a content of 51.67 mg GAE/gm of dry extract followed by ethanol extract 
which showed 42.90 mg GAE/gm of dry extract.  Ethyl acetate extract showed a 
total phenolic content of 34.60  mg GAE/gm of dry extract and petroleum extract 
showed a least phenolic content of 17.07 mg GAE/gm of dry extract (Table 3).    
  
          Total Phenolic content = Chloroform > Ethanol > Ethyl acetate > Petroleum 
ether 
  The total flavonoid content was determined by aluminium chloride 
colorimetric method and the results were expressed as quercetin equivalents. The 
total flavonoid content found to be high in chloroform extract which showed 428.97 
mg quercetin equivalent/gm of extract followed by petroleum ether extract which 
showed a total flavonoid content of 124.22 mg quercetin equivalent/gm of extract. 
The total flavonoid content in ethyl acetate extract and ethanol extract was found to 
be 28.01 and 22.67 mg quercetin equivalent/gm of extract respectively (Table 3). 
Total Flavonoid content = Chloroform > Petroleum ether > Ethyl acetate > 
Ethanol 
 The total tannin content was found to be high in chloroform extract which 
showed 80.88 mg tannic acid equivalents per g of dry extract. The total tannin 
content in ethanol content was found to be 64.38 mg tannic acid equivalents per g of 
dry extract.  Ethyl acetate and petroleum ether extracts showed a tannin content of 
48.74 and 15.73 mg tannic acid equivalents per g of dry extract (Table 3).  
Total Tannin content = Chloroform > Ethanol > Ethyl acetate > Petroleum 
ether 
Total antioxidant capacity  
Total antioxidant capacity of different solvent extracts of Cichorium intybus 
leaves were evaluated by phosphomolybdenum method and the results were 
expressed as ascorbic acid equivalents. Total antioxidant capacity of petroleum ether 
extract was found to be 633.30 μg ascorbic acid equivalent per mg of extract, 
  
Chloroform extract showed 1450.59 μg ascorbic acid equivalent per milligram of 
extract, ethyl acetate extract showed 104.47 μg ascorbic acid equivalent per mg of 
extract and ethanol extract showed 56.40 μg ascorbic acid equivalent per mg of 
extract (Table 3).  
Total Antioxidant activity = Chloroform > Petroleum ether > Ethyl acetate > 
Ethanol 
Free radical Scavenging activity 
The free radical scavenging activity of different solvent extracts of 
Cichorium intybus leaves were investigated using DPPH scavenging activity, nitric 
oxide scavenging activity, lipid peroxidation scavenging activity, cupric ion 
reducing assay, ferric reducing assay and metal chelating activity.  
DPPH radical scavenging activity  
The DPPH radical scavenging activity of various solvent extracts of 
Cichorium intybus leaves is shown in table 4 and fig 6. The ethyl acetate extract 
showed a significant dose-dependent inhibition of DPPH activity with a 50 % 
inhibition (IC50) at a concentration of 169.64 μg/ml. The IC50 of DPPH radical 
scavenging activity of ethanol extract was found to be 204 μg/ml, whereas 
petroleum ether and chloroform extract showed IC50 above 1000 μg/ml.  As lower 
IC50 values indicate  higher radical scavenging activity, ethyl acetate extract showed 
a potent DPPH radical scavenging activity compared to other solvent extracts. 
  
 
Nitric oxide scavenging activity 
The nitric oxide scavenging activity of various solvent extracts of Cichorium 
intybus leaves is shown in Table 4 and figure 7. It was observed that ethyl acetate 
extract showed a potent nitric oxide scavenging activity by reducing the amount of 
nitrite generated from the decomposition of sodium nitroprusside invitro with an 
IC50 value of 3.71 μg/ml followed by chloroform and petroleum ether extract with 
IC50 value of 4.30 μg/ml and 5.26 μg/ml respectively. Ethanol extract showed a least 
nitric oxide scavenging activity with an IC50 value of 81.30 μg/ml. 
Lipid peroxidation inhibitory activity 
The lipid peroxidation inhibitory activity of various solvent extracts of 
Cichorium intybus leaves is shown in table 4 and figure 8. It was observed that ethyl 
acetate extract showed a potent potent inhibitory effect on untrasound induced lipid 
peroxidation in liposome prepared from egg lecithin with an IC50 value of 9.83 
μg/ml followed by chloroform and petroleum ether extract with IC50 value of 12.37 
μg/ml and 19.55 μg/ml respectively. Ethanol extract showed a least Lipid 
peroxidation inhibitory activity among the solvent extract with an IC50 value of 
19.55 μg/ml 
CUPRAC assay 
CU2+ ion reducing capacity of Cichorium intybus leaf extract is shown in 
table 5 and expressed as trolox equivalent. CU2+ ion reducing capacity of petroleum 
ether was found to be 5866.52 μg of trolox equivalent per mg of extract.  CU2+ ion 
reducing capacity of chloroform extract was found to be 13398.87 μg of trolox 
  
equivalent per mg of extract. CU2+ ion reducing capacity of ethyl acetate extract was 
found to be 991.617 μg of trolox equivalent per mg of extract and CU2+ ion reducing 
capacity of ethanol extract was found to be 549.439 μg of trolox equivalent per mg 
of extract. 
Ferric reducing power assay   
The ferric reducing power of different solvent extracts is shown in fig 9. It 
was observed that the reducing ability of the extracts increased with the 
concentration. Among the extracts tested for the reducing abilities, ethanol extract 
showed a potent reducing power as shown by increased optical density at 700 nm 
followed by ethyl acetate and chloroform extract.  
Metal chelating activity 
Metal chelating activity of different extracts of Cichorium intybus leaves is 
shown in fig 10. The chelating of ferrous ion by the extract was estimated in the 
presence of other chelating agent, ferrozine. It was observed that in the presence of 
extract, the ferrozine complex formation is disrupted with the result that the red 
colour of the complex decreases. A dose dependent decrease in absorbance was 
noted. Among the different solvent extracts, ethanol extract showed a potent metal 
chelating activity followed by ethyl acetate, petroleum ether and chloroform extract.  
From the quantitative estimation of bioactive compounds and free radical 
scavenging of various solvent extracts of Cichorium intybus, it was observed that the 
chloroform extract was highly potent compared to other extract. Based on the 
observation, the chloroform extract was selected for in-vivo pharmacological study.  
  
 
In-vivo pharmacological activity 
Acute oral Toxicity study 
Acute oral toxicity study was carried out as per OECD guideline 425. From 
the limit test results it was observed that, the Cichorium intybus leaf extract was safe 
upto a dose level of 2000 mg/kg. There was no mortality and the experimental 
animals did not show any toxic effect throughout the observation period of 14 days 
(Table 6). 
Effect of Cichorium intybus leaf extract on body weight during N- 
nitrosodiethylamine (NDEA) induced hepatocarcinogenesis in rats 
Average body weights of different animal groups at various intervals are 
shown in Figure 11. There was no significant difference in final body weight 
between the control group (240 ± 2.88 g) and extract alone treated groups (Extract 
200 mg/kg- 235.5 ± 2.81 g, Extract 400 mg/kg- 245.2 ± 1.53 g). The final body 
weight of NDEA induced untreated animals (130.5 ± 3.5 g) was significantly less 
(p<0.001) compared to control animals (240 ± 2.88 g). The group V and group VI 
animals with NDEA induced and treated with extract 200 mg/kg and 400 mg/kg 
showed a significant increase (p<0.001) in final body weight (Extract 200 mg/kg- 
212.6 ± 2.47 g and Extract 400 mg/kg- 225.8 ± 3.0 g) compared to untreated 
animals. It shows the Cichorium intybus leaf extract prevented the body weight loss 
in NDEA induced animals and maintained the growth rate near normal.  
Relative liver weight 
  
The relative liver weight of control and experimental group of animals are 
shown in table 7 and figure 13. The results were expressed as g liver/100 g body wt. 
There was no statistical difference in relative liver weight between control (2.22 ± 
0.01) and extract alone treated groups (Extract 200 mg/kg - 2.18 ± 0.03, Extract 400 
mg/kg - 2.23 ± 0.03). The relative liver weight of group IV NDEA induced untreated 
animals (2.95 ± 0.06) were significantly increased (p<0.001) compared to Group I 
control animals. A significant decrease (p<0.001) in relative liver weight was noted 
in NDEA induced group V and group VI animals treated with extract 200 mg/kg 
(2.59 ± 0.05) and 400 mg/kg (2.52 ± 0.04). 
Gross morphology 
As depicted in figure 12, the appearance of liver in control group rats were 
normal and there were no macroscopically detectable changes in liver (Fig 12.A). 
No obvious changes in liver morphology were observed in extract alone treated 
group which is indicative of nontoxic nature of Cichorium Intybus leaf extract 
(Fig.12B and Fig.12C).  The rats in NDEA group revealed enlarged liver and 
multiple lesions (whitish) with almost the entire surface of liver is occupied with 
abnormal growth in posterior surface (Fig. 12D). In group of NDEA induced 
animals treated with Cichorium Intybus leaf extract 200 mg/kg, compared to NDEA 
control there was a marked reduction in damage caused by NDEA on gross 
examination of anterior and posterior surface. There were no detectable lesions or 
nodules (Fig. 12E). The liver of rats treated with Cichorium Intybus leaf extract 400 
mg/kg appeared similar to normal rat liver. Both anterior and posterior surface of 
liver appeared smooth and there were no detectable lesions or nodules (Fig. 12F). 
  
 
Effect of Cichorium intybus leaf extract on serum marker enzymes and 
hepatocarcinogenesis marker  
The effect of Cichorium intybus leaf extract on the activities of marker 
enzymes and serum protein levels in control and experimental groups are shown in 
table 8 and figure 14. A significant increase (P<0.001) in AST (69.33 ± 0.20), ALT 
(436.40 ± 10.38), ALP (465.80 ± 9.93) and GGT (56.38 ± 2.35) IU/L were observed 
in NDEA induced untreated animals compared to control animals with AST (11.47 
± 0.17), ALT (110.0 ± 0.92), ALP (215.3 ± 3.60) and GGT (12.67 ± 0.20) IU/L. The 
animals treated with Cichorium intybus leaf extract 200 mg/kg showed a significant 
decrease in AST, ALT, ALP and GGT levels of 16.15 ± 0.20 (p<0.001),  162.60 ± 
3.15 (p<0.001), 232.50 ± 6.40 (p<0.001) and 23.68 ± 0.90 (p<0.001) respectively 
compared to NDEA untreated animals. The animals treated with Cichorium intybus 
leaf extract 400 mg/kg showed significant decrease in AST, ALT, ALP and GGT 
levels of 12.17 ± 0.46 (p<0.001), 121.80 ± 1.63 (p<0.001), 221.5 ± 4.80 (p<0.001) 
and 15.22 ± 0.44 IU/L (p<0.001). The total protein levels were decreased (P<0.001) 
in NDEA untreated animals (4.78 ± 0.21) compared to control animals (7.88 ± 0.21). 
However, upon treatment with Cichorium intybus leaf extract 200 mg/kg and 400 
mg/kg the protein levels were significantly increased to 5.48 ± 0.17 (p<0.001) in 
animals treated with 200 mg/kg and to6.33 ± 0.16 mg/dl in animals treated with 400 
mg/kg (p<0.001).  
The effect of Cichorium intybus leaf extract on AFP and CEA levels in 
serum of control and experimental groups are shown in table 9 and figure 14.  A 
significant increase in AFP (0.89 ± 0.03 ng/ml) (p<0.001) and CEA (5.85 ± 0.14 
  
ng/ml) (p<0.05) were observed in NDEA induced untreated animals compared to 
control animals with AFP and CEA levels 0.52 ± 0.03 and 1.5 ± 0.14 ng/ml 
respectively. In group of animals treated with Cichorium intybus leaf extract, the 
AFP and CEA levels in serum were significantly reduced to 0.71 ± 0.02 and 4.08 ± 
0.24 ng/ml in animals treated with 200 mg/kg (p<0.001) compared to NDEA 
untreated animals. In group of animals treated with Cichorium intybus leaf extract 
400 mg/kg, the AFP and CEA levels in serum were significantly reduced to 0.59 ± 
0.03 and 2.44 ± 0.14 ng/ml compared to NDEA untreated animals. Non-significant 
alteration in serum marker enzymes and hepatocarcinogenesis marker in extract 
alone treated group II and group III animals when compared with control group I 
animals indicates the non-toxic nature of Cichorium intybus leaf extract. 
Effect of Cichorium intybus leaf extract on LPO and levels of antioxidant 
enzymes in liver 
The LPO levels in liver homogenate of control and experimental animals are 
illustrated in Table 10 and Figure 16. A significant increase (p<0.001) in the 
production of MDA (1.69 ± 0.15) was observed in the group IV NDEA intoxicated 
untreated animals compared to control animals (1.09 ± 0.08).  Administration of 
Cichorium intybus leaf extract showed a significant reduction in LPO as evidenced 
by a significant fall in MDA levels to 1.08 ± 0.07 (p<0.01) and 0.96 ± 0.03 
(p<0.001) at doses 200 mg/kg and 400 mg/kg respectively. 
Table 10 to Fig 16 portrays the activities and the levels of antioxidants in 
liver of control and experimental animals and the results were expressed as U/mg of 
protein. A significant decrease (p<0.001) in activities of SOD (0.85 ± 0.01) and 
catalase (0.85 ± 0.11) were noted in group IV NDEA intoxicated untreated animals 
  
compared to control animals with SOD (2.62 ± 0.13) and CAT (1.94 ± 0.11) levels.  
The levels of non-enzymatic antioxidants GSH (0.91 ± 0.02) were also significantly 
decreased (p<0.001) in liver of group IV untreated animals compared to control 
animals with GSH (2.26 ± 0.07). However, administration of Cichorium intybus leaf 
extract at 200 mg/kg and 400 mg/kg significantly increased the levels of SOD and 
CAT to near normal levels. The SOD levels in liver of animals treated with extract 
200 mg/kg and 400 mg/kg were significantly increased to 1.78 ± 0.03 and 2.36 ± 
0.12 (p<0.001) respectively compared to NDEA untreated animals. Extract 200 
mg/kg and 400 mg/kg significantly increased the CAT levels to 1.14 ± 0.08 and 1.41 
± 0.09 (p<0.001) respectively compared to NDEA induced untreated animals. 
Similarly, administration of extract 200 mg/kg and 400 mg/kg significantly 
increased the non-enzymatic antioxidants, GSH to levels 1.74 ± 0.04 and 1.93 ± 0.04 
respectively compared to NDEA induced untreated animals.  
The extract did not produce any deleterious effect on the antioxidant defense 
system in normal animals which is evidenced from the non-significant alteration of 
the enzymatic and non-enzymatic antioxidants along with the maintained rate of 
lipid peroxidation in group II and group III animals when compared with the normal 
control group I animals. The results indicate that, the level of lipid peroxidation 
which increased in liver of carcinogen administered animals was lowered in extract 
treated animals and in contrast the antioxidant status which was found to be 
decreased in carcinogen administered animals was improved to near normal upon 
Cichorium intybus leaf extract administration. This indicates that Cichorium intybus 
leaf extract contributes to exert antioxidant defense mechanism. 
  
 
Histopathology 
Histopathological examination of liver sections from control group animals 
revealed normal architecture (Fig. 17 A). The liver sections of group II and group III 
animals given extract alone for 16 weeks showed normal architecture. The portal 
tracts were normal. The hepatic parenchyma showed normal hepatocytes. The 
central vein and sinusoids appeared normal. There is no evidence of inflammation or 
malignancy or atypical cells depicting the non-toxic nature of Cichorium intybus 
leaf extract (Fig. 17 B and Fig. 17 C). Section of liver from group IV NDEA 
induced untreated animals revealed loss of architecture with portal tract 
inflammation with infiltration of lymphocytes (Fig. 17 D). In contrast, NDEA 
induced animals treated with Cichorium intybus leaf extract 200 mg/kg showed 
chronic portal tract inflammation with periportal macrovesicular steatosis (Fig. 17 
E), whereas the liver sections of NDEA induced animals treated with Cichorium 
intybus leaf extract 400 mg/kg showed normal hepatic architecture (Fig. 17 F). The 
portal tracts were normal and the hepatic parenchyma showed normal hepatocytes 
with no evidence of cirrhosis (40×, HE). 
 
  
 
DISCUSSION 
Liver cancer, one of the most common cancer worldwide, accounts 
approximately 549,000 deaths each year (Liu et al., 2006). As liver, the major 
metabolic organ in our body is responsible for production of ROS during 
metabolism of carcinogens might be responsible for carcinogenic effects. N-
nitrosodiethylamine (NDEA), one of the most important environmental carcinogen 
on metabolic transformation in liver produces ROS that act as promutagenic 
products is responsible for carcinogenic effects (Bansal et al. 2005). Therefore, 
development of a compound with potent antioxidant activity can prevent the 
formation of ROS and thus provide protection against the deteriorating outcome. 
Traditionally many herbal medicines have revealed cancer chemopreventive 
potential through antioxidant activity. The present study was aimed to evaluate the 
chemopreventive and antioxidant activity of chloroform extract of Cichorium 
intybus leaves against N-nitrosodiethylamine induced hepatocarcinogenesis. As a 
preliminary study, the radical scavenging and invitro antioxidant activity of different 
solvent extracts of Cichorium intybus Linn.leaves were investgated. The preliminary 
phytochemical screening showed the presence of phenolics, tannins and flavonoids 
which are the major constituents of antioxidant activity, so it is dual necessary to 
estimate the bioactive compounds in various solvent extracts. Highest content of 
phenolic, tannins and flavonoids were noted in chloroform extract in comparison 
with other solvent used in quantitative analysis. The increased polarity made this 
organic solvent an ideal and selective to extract a great number of bioactive phenolic 
compounds. This indicated that the highest total antioxidant activity observed in 
  
chloroform extract of Cichorium intybus leaves is also due to the presence of high 
phenolics, tannins and flavonoids content. The radical scavenging and antioxidant 
activity of solvent extracts were demonstrated using different in vitro bioanalytical 
methodologies. Various antioxidant assay methods have been developed to identify 
antioxidant capacity.  
DPPH radical scavenging activity is the oldest method for determining the 
antioxidant activity. DPPH is astable nitrogen centered free radical which can accept 
an electron or hydrogen radical to become a stable diamagnetic molecule. Any 
molecule that can donate an electron or hydrogen to DPPH can react with it and 
thereby bleach the DPPH absorption. DPPH is a purple colour dye having 
absorption maximal of 517 nm and upon reaction with hydrogen donar the purple 
colour fades or disappears due to conversion of it to 2,2-diphenyl-1-picryl hydrazine 
resulting in decrease in absorbance (Kumarasamy et al., 2007). Substances which 
are able to perform this reaction can be considered as antioxidants and therefore 
radical scavengers. In the present study, it was found that the radical scavenging 
activity of chloroform extract of Cichorium intybus leaves is relatively high 
compared to other solvent extracts. This might be due to the H+ donating capacity 
due to the significant presence of flavonoids and phenolic compounds. 
Nitric oxide is an important regulatory molecule involved in the regulation of 
various physiological functions such as neurotransmission, vascular homeostasis, 
inhibition of platelet aggregation, regulation of cell mediated toxicity and 
importantly for host defense. It acts as a signal molecule in immune, nervous and 
vascular systems. However, excess production of nitric oxide is associated with 
several diseases (Karmakar et al., 2011). The toxicity of nitric oxide increases 
  
greatly when it reacts with superoxide radical, forming highly reactive peroxy nitrite 
anion (ONOO-). Therefore compounds with potent nitric oxide inhibition will be 
valuable for therapeutic use (Hepsibha et al., 2010). The principle of the present 
study is sodium nitroprusside in aqueous solution at physiological pH spontaneously 
generates nitric oxide which interacts with oxygen to produce nitrite ions that is 
estimated using Griess reagent. Scavengers of nitric oxide compete with oxygen, 
leading to reduced production of nitrite ions (Ebrahimzadeh et al., 2009). In the 
present investigation chloroform extract of Cichorium intybus exhibited a potent 
nitric oxide scavenging activity which might be due to inhibition of nitric oxide 
formation by directly competing with oxygen in reaction with nitric oxide. 
Lipid peroxidation has long been thought to be a toxicological phenomenon 
that can lead to various pathological consequences (Hochstein and Atallah, 1998). 
ROS, such as hydroxyl radical initiate’s lipid peroxidation by extracting a hydrogen 
atom from lipids forming conjugated lipid radical. This reacts rapidly with oxygen 
to form a lipid radical, until chain reaction is terminated. The lipid peroxidation 
adducts induce the oxidation of biomolecules such as DNA, proteins and other lipids 
resulting in cellular damage (Resat et al. 2007; Huong et al., 1998). Since lipid 
peroxidation is found to be important cause of cell membrane destruction and cell 
damage, their detoxification appears to be critical for the survival of an organism in 
oxidative stress (Dargel, 1992). Therefore antioxidants play a vital role in inhibition 
of lipid peroxidation or protection against cellular damage by free radicals. It is 
reported that phenolic and flavonoids are powerful antioxidants which can scavenge 
lipid free radical. In the present study, the high peroxidation scavenging effect of 
chloroform extract of Cichorium intybus leaves might be due to the presence of 
  
phenolic and flavonoid content which can terminate peroxidation chain reaction 
easily and quench reactive oxygen and nitrogen species, thereby inhibiting the 
oxidation of lipid and other biological molecules. 
Reducing power is associated with antioxidant activity and may serve as a 
significant indicator of potential antioxidant activity (Gulcin, 2010).  Compounds 
which are electron donars can reduce the oxidised intermediates of lipid 
peroxidation processes, which in turn act as primary and secondary antioxidants 
(Yen and Chen, 1995). In the present study ferric reducing antioxidant capacity and 
cupric reducing antioxidant capacity (CUPRAC) were used for the measurement of 
reducing capacity of extract. Both the methods are based on electron transfer and are 
considered as good indicator for total antioxidant power (Tezcan et al., 2011). Ferric 
reducing antioxidant capacity is based on reduction of Fe3+ to Fe2+ by antioxidants. 
CUPRAC assay is based on reduction of Cu2+ to Cu+ by antioxidants. This method is 
suitable for variety of antioxidants regardless of chemical type or hydrophilicity. 
Moreover, the results obtained from invitro cupric ion (Cu2+) reducing 
measurements might be more efficiently extended to the possible invivo reactions of 
antioxidants (Gulcin and Dastan, 2007; Karaman et al., 2010). In the present study, 
chloroform extract exhibited the most reducing power and by correlating the results 
with quantitative analysis, the reducing power of extract might be due to the 
presence of high phenolic content because phenolic compounds usually show high 
reducing capacity. 
As a catalyst of oxidative process, bivalent transition metal ions play an 
important role in the formation of hydroxyl radical and hydroperoxide 
decomposition reactions (Halliwell, 1997). Peroxides which are capable of 
  
generating free radicals may be implicated in human cardiovascular diseases 
(Halliwell  and Gutteridge, 1990). Because of Fe2+ causes the production of 
oxyradicals and lipid peroxidation, minimizing its concentration affords protection 
against oxidative damage. Chelating agents which form complex with metal ion are 
found to be effective in reducing the redox potential and thereby stabilizing the 
oxidized form of metal ion (Gordon, 1990). In the present study, the chloroform 
extract of Cichorium intybus leaves efficiently interfered the formation of ferrous 
and ferrozine complex, suggesting that the ethanol extract of Cichorium intybus 
leaves has good chelating effect and is able to capture ferrous ion before ferrozine.     
Dose levels for in-vivo pharmacological screening were selected based on the 
acute oral toxicity study and our previous in-vivo studies, where the extract showed 
protection against CCl4 induced hepatotoxicity in dose levels of 250 mg/kg and 500 
mg/kg.  In the present study two dose levels 1/10th and 1/5th of 2000 mg/kg were 
selected from the acute toxicity study, where the extract was found to be safe up to a 
dose level of 2000 mg/kg. 
Decrease in body weight observed during the experimental period in NDEA 
induced untreated animals could be largely due to deterioration of liver function and 
nutritional deprivation which might be due to reduced food intake. In addition, 
assessment of relative liver weight was used as potential tool to diagnose change in 
liver size. NDEA induced proliferation of cells in the liver was evident from 
increase in NDEA induced untreated animals. Treatment with Cichorium intybus 
leaf extract prevented body weight loss and reduced the relative liver weight 
compared to untreated animals, which signify the amelioration capacity of extract 
upon carcinogen exposure. Significant decrease in lesions in liver of treatment 
  
groups were supported by histological assessment of liver. The pathological changes 
in liver caused by NDEA were assessed by determining the levels of various 
biochemical hepatic markers (Kovalsky et al., 1996). Marked elevation in AST and 
ALT in NDEA induced untreated animals indicated the hepatocellular damage. 
Because AST and ALT are cytoplasmic in location, they are released into circulation 
after cellular damage and rupture of plasma membrane (Wroblewski, 1959; Sallie             
et al., 1951). Hence AST and ALT are considered as sensitive markers employed in 
diagnosis of hepatic damage. Treatment with Cichorium intybus leaf extract 
significantly reduced the levels of AST and ALT in NDEA induced animals. This 
indicates that Cichorium intybus leaf extract tends to prevent liver damage by 
maintaining integrity of plasma membrane, thereby suppressing the leakage of 
enzymes through membrane. 
The elevation in ALP in NDEA induced untreated animals might be due to 
proliferation of bile ductular cells and resulting blockade of bile ducts. Significant 
reduction in ALP levels in NDEA induced extract treated animals indicates the 
protective effect of Cichorium intybus  leaf extract against NDEA induced hepatic 
injury. The reduction in serum protein levels in NDEA induced untreated animals 
might be due to liver damage because hepatotoxicity impairs the synthetic function 
of liver (David, 1999). Treatment with Cichorium intybus leaf extract ameliorated 
the imbalance. 
GGT, an enzyme embedded in plasma membrane of hepatocytes, mainly in 
canalicular domain. Any damage in plasma membrane causes liberation of GGT into 
serum (Sivaramakrishnan et al., 2008). Hence, GGT is considered as a best indicator 
of liver damage (Bulle et al., 1990). Elevated levels of GGT observed in NDEA 
  
induced untreated animals might be due to liver injury. Treatment with Cichorium 
intybus  leaf extract significantly lowered the GGT level which indicates that 
Cichorium intybus  leaf extract tends to prevent liver damage by maintaining 
integrity of plasma membrane. 
 A tumour associated foetal protein, AFP has long been employed as a serum 
tumour marker to monitor disease progression (Abelev, 1971). AFP is a 72 KDa α1 
globulin synthesized during embryonic life by foetal yolk sac, liver and intestinal 
tract with uncertain biological function. Since AFP has high specificity for 
hepatocarcinoma (Liu et al., 2006), its serum concentration can be used in diagnosis 
of hepatocarcinoma and for the diagnosis of tumour response to therapy. 
CEA is a glycoprotein found in different cells, but typically associated with 
certain tumours. Increase in CEA levels is most frequent in cancer of colon and 
rectum. The conditions which can elevate CEA are smoking, pancreatitis, 
inflammatory bowel disease, pancreatitis and cirrhosis of liver. CEA levels increase, 
with an increase in tumour size (Jahan et al., 2011). In the present study, significant 
increase in AFP and CEA levels observed in NDEA induced untreated animals 
might have caused due to mutagenesis. The decrease in levels of AFP and CEA 
following treatment with Cichorium intybus leaf might be due to response to 
therapy.   
Increased ROS generation and decreased antioxidant defense in liver tissue 
has been reported in development of hepatocarcinogenesis (Ramakrishnan et al., 
2006; Kweon et al., 2003). ROS, through interaction with nucleic acids, proteins, 
lipids results in chromosomal instability, mutations, loss of organelle function play 
an important role in development of cancer (Waris and Ahsan, 2006). Lipid 
  
peroxidation is one of the major mechanisms of cell injury caused by free radicals. 
Enormous amount of free radicals generated by carcinogens reacts with lipids 
causing lipid peroxidation (Sikkim and Mulee 2000).  The products of lipid 
peroxidation include malondialdehyde that interacts with various molecules leading 
to oxidative stress and has been reported to be involved in the formation of tumours 
(Ramakrishnan et al., 2007). In the present study, significant increase in the levels of 
lipid peroxidation observed in untreated group IV cancer bearing animals may be 
due to the excessive production of free radicals and due to inhibition of antioxidant 
enzymes. Significantly reduced levels of lipid peroxidation were seen in Cichorium 
intybus  leaf extract treated group V and group VI NDEA induced animals. This 
clearly shows that Cichorium intybus effectively controlled the rate of lipid 
peroxidation, which suggests the beneficial effect of the extract against NDEA 
initiated free radical formation. The presence of flavonoids may contribute to this 
effect, because they are proved to be a potential inhibitor of lipid peroxidation 
(Siegers and Younes, 1981).  
 The enhanced formation of lipid peroxides is further evidenced by decrease 
in activities of antioxidant enzymes in liver of NDEA induced untreated animals as 
compared with normal control animals. 
 SOD is said to act as the first line of defense against superoxide radical 
generated as a by-product of oxidative phosphorylation. SOD mediated dismutation 
of superoxide radical (O2-) generates hydrogen peroxide (H2O2). Accumulation of 
excess of H2O2 causes toxic effects on cellular system. In this regard catalase 
converts H2O2 into water (Li Shijun et al., 2000). CAT detoxifies H2O2 into H2O and 
O2 (Murray et al., 2003). Thus SOD and act mutually and constitute the enzymatic 
  
defense mechanism against ROS (Bhattacharjee and Chatterjee, 1998). In the 
present study decrease in the activities of SOD and CAT in untreated cancer bearing 
animals could be attributed to excessive utilization of enzymes in detoxification of 
peroxides and hydroperoxides generated during liver carcinogenesis. Restoration in 
the levels of lipid peroxidation upon treatment with Cichorium intybus  leaf extract 
might have resulted in the recoupment in the activities of the above antioxidant 
enzymes to normalcy. 
 GSH is a well known non-enzymatic antioxidant defense system of cells, act 
synergistically to scavenge free radicals in biological system. GSH is found to be 
present in high concentration in cells, protects cells against free radical attack 
(Farombi et al., 2000). GSH acts directly as free radical scavenger by donating a 
hydrogen atom and thereby neutralizing hydroxyl radical. It reduces peroxides and 
maintains protein thiols in the reduced state (Nwanjo and Oze, 2007). GSH-PX uses 
GSH as a substrate to catalyze the reduction of hydroperoxide and H2O2 (Bebe and 
Panemangalore, 2003). Reduced glutathione (GSH) in tissues maintains maintains 
the cellular levels of vitamin C and Vitamin E in active form. It removes free 
radicals from cytosol and plays a vital role in protecting lipoprotein molecules from 
oxidative damage by regenerating the reduced form of vitamin E (Das, 1994). GSH 
acts synergistically with vitamin E against oxidative stress (Chaudiere, 1994). 
Vitamin C also scavenges and detoxifies free radicals in combination with Vitamin 
E and GSH (George, 2003). The decreased level of GSH observed in NDEA 
induced untreated animals might be due to excessive utilization of these antioxidants 
for quenching enormous free radicals produced. Treatment with Cichorium intybus 
leaf extract effectively restored the depleted levels of non-enzymatic antioxidants 
  
GSH caused by NDEA. Increase in GSH levels in turn also contributes to the 
recycling of other antioxidants such as vitamin C and vitamin E.      
 The results indicate that Cichorium intybus leaf extract inhibits the level of 
lipid peroxidation and significantly increases the enzymatic and non-enzymatic 
antioxidant defense mechanisms in NDEA induced liver carcinogenesis. 
 The histological observations clearly indicate the presence of cirrhotic 
changes in NDEA induced untreated animals. In animals treated with Cichorium 
intybus  leaf extract the liver architecture was preserved which clearly supports the 
biochemical data. These suggest the Cichorium intybus leaves might have promising 
protective role against liver carcinogenesis.   
  
 
CONCLUSION 
 
This study suggest that administration of chloroform extract of Cichorium 
intybus leaves possesses a significant protection against NDEA induced liver 
carcinogenesis by a mechanism related, at least in part, to the ability of Cichorium 
intybus leaves to decrease oxidative stress by stabilizing and increasing all the 
components of antioxidant defense system which were disturbed system during 
NDEA induced oxidative stress in rats. The chloroform extract of Cichorium intybus 
leaves was found to be rich in flavonoids, phenolics and tannins and showed a 
potent free radical scavenging activity screening in in-vitro analysis. Since 
flavonoids, phenolics and tannins are powerful antioxidants, their presence in 
Cichorium intybus leaf extract might be responsible for antioxidant property, which 
might be involved in the chemoprevention against hepatocarcinogenesis. 
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